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Abstract
The effects of neurotrophic factors on enteric ganglion cells were studied using variety of 
techniques. NT-3 was found to have protective effects on enteric neurons exposed to hydrogen 
peroxide. The second neurotrophic factor tested, GDNF, did not exhibit a similar, protective 
effect. Investigation of the effects of these factors on the levels of catalase and SOD Cu/Zn 
revealed that NT-3 does not affect levels of either enzyme after 12 and 36 hour incubation. In 
contrast to NT-3, GDNF was able to increase the levels of both enzymes, although this effect 
was observed only at the 36 hour time point. To investigate the mechanism of NT-3 induced 
protective effects, the signalling pathways initiated by NT-3 were also studied. PI-3K, an 
enzyme known to play a role in the survival responses initiated by trophic factors in many cell 
types was blocked using a specific inhibitor, LY294002. As a result, a dramatic decrease in 
cell numbers was observed in control as well as NT-3 and GDNF treated cultures. Inhibition 
of PI-3K also nullified the effects of trophic factors on the cells. Subsequently, the effects of 
NT-3 and combined NT-3/LY294002 treatment on the activity of several signalling proteins 
were examined. Control cultures showed steady, easily detectable levels of phosphorylated 
Akt, as well as total protein levels of bcl-2 and c-fos, which were independent of signalling 
initiated by addition of exogenous NT-3. In contrast, phosphorylation of MEK and ERK 
proteins was dependent upon exogenous NT-3. LY294002 treatment severely reduced the 
amount of phosphorylated Akt present in the cells. Additionally, the presence of 
phosphorylated MEK and ERK was observed at the point of NT-3 treatment, suggesting that 
in was independent of exogenous NT-3. Total protein levels of bcl-2 and c-fos proteins in the 
LY294002 treated cultures were elevated compared to controls.
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Chapter 1
Introduction
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Introduction
The enteric nervous system (ENS) is intrinsic to the digestive tract, and constitutes a part of 
the autonomic nervous system that innervates the gut. Although sympathetic and 
parasympathetic nervous systems also take part in the regulation of intestinal function the ENS 
is by far the most important and is unique in that it can function relatively independently of the 
control of the central nervous system (CNS). Functions of the ENS include the control of 
intestinal motility, secretion and blood flow. The ENS, like most of the peripheral nervous 
system, originates from the multipotent precursor cells of the neural crest that, after following 
specific pathways of migration, invade the entire gut. These enteric crest-derived cells respond 
to diffusible factors as well as extracellular matrix proteins generated by the 
microenvironment of the gut by differentiating into the cells of the enteric plexuses 
[Chalazonitis et al. 1996, Gershon et al. 1992]. It has been demonstrated that neurotrophic 
factors play an important role in the maturation process by promoting the differentiation of 
multipotent cells into enteric neurons and glia, and stimulating neurite outgrowth in vitro 
[Stemini et al. 1996, Chalazonitis et al. 1994,Yamamori et al. 1992]. In addition to their role in 
the development of the ENS, neurotrophic factors are also believed to be responsible for the 
plasticity of the nervous system in adults [Cowen et al. 1996].
This introductory chapter provides a general overview of the ENS, the neurotrophic factors 
acting on enteric neurons and a brief discussion of changes observed in the ENS during aging. 
Subsequent chapters contain detailed information describing the effects of oxidative stress on 
ENS (chapter 3), antioxidant enzymes involved in protecting enteric ganglion cells from free 
radicals (chapter 4) and finally, signalling pathways underlying actions of the neurotrophic 
factors on enteric neurons and glia (chapter 5).
15
1.1 Structure of the ENS.
The ENS consists of a number of interconnected networks, or plexuses. Two of those plexuses 
(the myenteric and submucous plexus) contain small groups of nerve cell bodies, called the 
enteric ganglia [Gershon et al. 1992, Costa et al. 1987]. (Fig. 1.1).
M yen 1er je 
plexus
Longitudinal ^ 
m uscle
Circular Deep muscular 
m uscle plexus
Subm ucous 
plexusm i
'rh.'*
Villous
plexus
Periglandular
plexus
Figure 1.1 Structure o f  the ENS, Modified from [Costa et al. 1987]
The structure of the ENS is different from that of other peripheral nerves and ganglia. 
Collagen is excluded from the enteric ganglia and support for neuronal elements is provided 
by enteric glial cells, which share some similarities with astrocytes. Enteric glia differ from 
Schwann cells in that they do not form basal laminae and they ensheath axons, not 
individually but in groups [Costa et al. 1987].
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The myenteric plexus is a network of nerve strands and small ganglia that lies in the plane 
between the external longitudinal and circular muscle coats of the intestine.
The network is continuous around the circumference of the gastrointestinal tract and along its 
length. The myenteric ganglia vary in size, shape and orientation from species to species and 
from one part of the intestine to another, but in any one area from a particular species the 
shape of the meshwork is quite characteristic and readily identified. Although the pattern is 
easily recognised in any one area, considerable variations in the sizes of ganglia are 
encountered. In the ileum of the guinea pig, myenteric ganglia range in size from 5 to 160 
nerve cell bodies, with an average of 43 cell bodies per ganglion [Costa et al. 1987].
Within the submucosa there is a network of small ganglia and connecting strands which form 
the submucous plexus. The meshes of the submucous plexus are smaller than those of the 
myenteric plexus, the interconnecting strands are finer and the ganglia smaller. In the guinea 
pig small intestine, ganglia vary in size from single cells to groups of 30, with an average of 
eight, which is about one-fifth of the ganglion size in the myenteric plexus. The plexus is 
continuous along the circumference and along the length of the intestine. The ganglia often lie 
at two levels, one group being closer to the muscle, the other closer to the mucosa. [Wilson et 
al. 1981, Hoyle et al. 1989].
1.2 Neurotransmitters and neurons found in the ENS.
First attempts to classify enteric neurons date back to the late nineteenth century and the 
research of Dogiel, who identified at least three main classes of nerve cells based on their 
morphology (types I, II and III), [see Costa et al. 1989]. The first two cell types recognised by 
Dogiel have received the most attention, because they are easily detected in many species by a
17
variety of stains and their function has been elucidated. Dogiel type I neurons are often 
flattened in the plane of the ganglion in which they lie. A subset of Dogiel type I neurons has 
been identified as motor neurons. These cells have distinctly oval cell bodies, a single long 
process that is probably an axon, and, most characteristically, many paddle shaped lamellar 
dendrites projecting from the cell body. The cell bodies of Dogiel type II neurons are more 
spherical than those of type I cells and they give rise to several long processes, so that no 
single process can be distinguished as the axon. Research on the guinea pig identified a 
subpopulation of these neurons as the intrinsic primary afferent neurons [Kunze et al. 1999]. 
Type III cells have oval to spherical cell bodies, a single long axon, and many long thin 
dendrites that exhibit complex patterns of arborisation. Two additional cell types have been 
revealed by intracellular injections of the tracer: a filamentous cell with a single recognisable 
axon and even greater abundance of thin dendritic processes than the type II cell, and small 
simple neurons with few dendrites and a single recognisable axon. As many as ten different 
types of neurons have been described in the guinea pig myenteric plexus using ultrastructural 
criteria [Cook et al. 1976], however, it is not easy at this point to relate the ultrastructural 
classification of neurons to that of Dogiel.
In addition to classification based on cell morphology, enteric neurons have also been 
categorized according to their content of neurotransmitters. The ENS contains many 
neurotransmitters, and in many cases two or more neurotransmitters are present in one neuron 
[Furness et al. 2000, Legay et al. 1984]. There is good evidence in intestinal nerves for the 
presence of acetylcholine, cholecystokinin, dynorphin, met-enkephalin and leu-enkephalin, 
galanin, gastrin releasing peptide and a shorter form, neuropeptide Y, peptide HI, 
somatostatin, substances K, P and vasoactive intestinal peptide (Table 1.1).
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Type o f  neuron
Proportion o f total 
neuronal population Chemical coding
Excitatory circular muscle motor 
neurons
12% ChAT/TK/ENK/GABA
Inhibitory circular muscle motor 
neurons
16% NOS/VIP/PACAP/ENK/NPY/GABA
BN/NFP/Dynorphin
Excitatory longitudinal muscle motor 
neurons
25% ChAT/Calretinin/TK
Inhibitoiy longitudinal muscle motor 
neurons
2% NOS/VIP/GABA
Ascending intemeurons 
(local reflex)
5% ChAT/Calretinin/TK
Descending intemeurons 
(secretomotor reflex)
2% ChAT/5-HT
Descending intemeurons 
(migrating myoelectric complex)
4% ChAT/SOM
Myenteric intrinsic primary afferent 
neurons 26% ChAT/Calbindin/TK/NKs receptor
Intestinofugal neurons
*Non cholinergic 
secretomotor/vasodilator neurons
<1%
45%
ChAT/BN/VIP/CCK/ENK
VIP/GAL
*Cholinergic secretomotor/vasodilator 
neurons
* Cholinergic secretomotor (non 
vasodilator) neurons
15% ChAT/Calretinin/Dynorphin
* Submucosal intrinsic primary afferent 
neurons
29% ChAT/NPY/CCK/SOM/CGRP/Dynorphin
11 % ChAT/TK/Calbindin
Table 1.1 Types o f  neurons in the enteric nervous system and their neurotransmitters. Data based on the 
percentages o f  total neuronal population and neurotransmitters found in guinea pig small intestine. BN, 
bombesin; CCK, cholecystokinin; ChAT, choline acetyltransferase; CGRP, calcitonin gene related peptide; ENK, 
enkephalin; GABA, gamma amino butyric acid; GAL, galanin; 5-HT, 5-hydroxy-tryptamine; NFP, neurofilament 
protein; NK, neurokinin; NOS, nitric oxide synthase; NPY, neuropeptide Y; PACAP, pituitary adenylyl cyclase 
activation peptide; SOM, somatostatin; TK, tachykynin; VIP, vasoactive intestinal peptide. * Neurons located in 
submucous plexus. Adapted from [Furness et al. 2000].
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The presence of serotonin in enteric neurons was confirmed by immunohistochemical staining 
[Legay et al. 1984]. One subset of enteric neurons, the enteric inhibitory neurons contain nitric 
oxide synthase and release nitric oxide. Although there is a good evidence that nitric oxide is a 
transmitter of these neurons, it is clear that it is not the sole transmitter, which was proved by 
knock out experiments in which gastrointestinal tract is little affected by the absence of nitric 
oxide synthase [Huang et al. 1994], and from incomplete block of transmission from enteric 
inhibitory neurons when nitric oxide synthase is blocked.
Different experiments indicate that most neurons contain more than one neurotransmitter 
[Costa et al. 1986, Furness et al. 1987]. For instance dynorphin, enkephalin and vasoactive 
intestinal peptide coexist in a significant proportion of type I neurons. A population of type III 
neurons contain cholecystokinin, calcitonin gene-related peptide, choline acetyltransferase (a 
marker of cholinergic neurons) and galanin. Some of the type I neurons contain nicotinamide 
adenine dinucleotide phosphate diaphorase (NADPH diaphorase), and a proportion of these 
neurons also contain neuropeptide Y [Gershon et al. 1986]. It is likely that other combinations 
of neurotransmitters also exist within enteric neurons.
In functional terms, the ENS comprises several types and many subtypes of neurons, some of 
which are listed in Table 1 and shown in Figure 1.2. Enteric motor neurons can be 
divided into excitatory neurons to the gut muscle, inhibitory neurons to gut muscle, 
secretomotor/vasodilator neurons, secretomotor neurons that are not vasodilator and neurons 
innervating the gastrin secreting endocrine cells of the stomach.
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Figure 1.2 Types o f neurons in the small intestine of the guinea pig.
1 .Ascending intemeuron, 2. Myenteric intrinsic primary afferent neuron, 3. Intestinofugal neuron,
4. Excitatory longitudinal muscle motor neuron 5. Inhibitory longitudinal muscle motor neuron,
6. Excitatory circular muscle motor neuron, 7. Inhibitory circular muscle motor neuron, 8. Descending 
intemeuron (local reflex) 9. Descending intemeuron (secretomotor reflex) 10. Descending intemeuron (migrating 
myoelectric complex), 11. Submucosal intrinsic primary afferent neuron, 12. Non cholinergic 
secretomotor/vasodilator neuron, 13. Cholinergic secretomotor/vasodilator neuron, 14. Cholinergic secretomotor 
(non vasodilator) neuron. Modified from [Kunze et al. 1999]
Three types of extrinsic motor neurons directly innervate effectors in the gut: vagal motor 
neurons to the striated muscle of the esophagus, noradrenergic neurons that innervate ganglia 
and blood vessels in the gut as well as gut muscle and noradrenergic vasoconstrictor neurons 
that innervate arteries within the gut wall. All regions of the gut and each of the muscle layers 
receive an intrinsic excitatory innervation. It has been shown that excitatory transmission has a 
prominent muscarinic component, however there is a small residual excitation independent of 
it, most likely due to the release of tachykinins. Consistent with this observation, motor 
neurons are immunoreaetive for both choline acetyltransferase (ChAT) and for tachykinins. 
The relative roles of tachykinins and ChAT are unequal since muscarinic antagonists 
substantially inhibit gastrointestinal motility in vivo [Galligan et al. 1986] whereas tachykinin 
antagonists have little effect. These observations suggest that acetylcholine is the primary
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transmitter of excitatory muscle motor neurons. Inhibitory muscle motor neurons are the 
motor neurons that mediate the descending inhibitory reflexes and accommodation reflexes in 
the gut [Furness et al. 1987]. They contain nitric oxide (NO), which has been shown in many 
vertebrate classes including mammals. Although NO is readily detected, it is not the only 
neurotransmitter present in these neurons [Makhlouf et al. 1993]. The proof that NO is not the 
only neurotransmitter comes from gene knockout experiments, in which the gastrointestinal 
tract is affected only in small degree by the absence of nitric oxide synthase [Huang et al. 
1994], and also from the incomplete block of transmission from enteric inhibitory neurons 
when NO synthase is blocked, or NO scavengers are used. There is some evidence that NO 
independent transmission might be attributed to ATP, VIP, PACAP and carbon monoxide. 
Electron microscopy studies suggest that all these different neurotransmitters come from the 
same neurons, since they detect only one population of inhibitory neurons, immunoreaetive for 
NOS, VIP and PACAP [Costa et al. 1996]. There are four types of intemeurons in the guinea 
pig intestine, one orally directed, and three types of anally directed. Orally directed neurons 
are cholinergic and like anally directed neurons form chains that extend along the gut. The 
three types of descending intemeurons have the following chemical codings: ChAT/NOSWIP, 
ChAT/SOM and ChAT/5-HT.
Studies of these neuronal classes have lead to the hypothesis that the first type, the 
Ch AT/NOS/VIP neurons are involved in the conduction of migrating myoelectric complexes 
in the small intestine, and the Ch AT/5-HT neurons are involved in secretomotor reflexes, but 
not directly in the motility reflexes [Pompolo et al. 1998]. The ChAT/SOM neurons are also 
distinctive in their morphology, having cell bodies with branching filamentous dendrites. 
Filamentous neurons with anally directed axons are not found in the distal colon, however in 
the colon there are filamentous neurons with orally directed processes.
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Evidence for the existence of intrinsic primary afferent neurons in the gut comes from the 
studies that recorded reflexes in isolated intestine after extrinsic nerves supplying the intestine 
have been cut and their endings degenerated [Crema et al. 1970]. They were directly identified 
in the small intestine of the guinea pig, where these are Dogiel type II neurons [Bertrand et al. 
1997]. Dogiel type II neurons with similar electrophysiological properties, projections and 
neurotransmitters have also been found in the large intestine of the guinea-pig and in the small 
intestine of the rat, which suggests that these neurons are also intrinsic sensory neurons.
The neurons responsible for controlling the balance of absorption and secretion of electrolytes 
are intrinsic secretomotor neurons. They are controlled through local reflex circuits, which in 
turn remain under control of the central nervous system. To date, two types of intestinal 
secretomotor neurons, cholinergic and non-cholinergic have been identified. In addition, 
release from the ends of intrinsic primary neurons in the mucosa may also have secretomotor 
effects. The non-eholinergic neurons appear to mediate most of the local reflex responses and 
use VIP or related peptide as their main neurotransmitter [Reddix et al. 1994].
In the guinea-pig small intestine there are two types of cholinergic secretomotor neurons, 
those that also contain NPY, and those that contain calretinin. There is also a single class of 
non-cholinergic secretomotor neurons which is immunoreaetive for VIP. The ACh/calretinin 
neurons preferentially innervate the glands at the base of the mucosa and have collaterals to 
submucosal arterioles, whereas the ACh/NPY neurons do not innervate the arterioles. The 
presence of three classes of secretomotor neurons, two of which also provide vasodilator 
collaterals could provide a mechanism to balance secretion and vasodilation depending on 
digestive state.
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Although the majority of ENS research has concentrated on guinea pig, there are also some 
studies addressing the questions of neurotransmitters and neuronal circuitry present in rat 
ENS, which shares many similarities with guinea pig ineluding similar major classes of 
neurons [Mann et al. 1998].
1.3 Development of the enteric nervous system
The ENS is derived from the neural crest. Prospective enteric neural crest cells emigrate from 
two main regions of the neural tube: the vagal and sacral regions. Cells from a third region that 
lies within the truncal crest colonize only the rostral foregut, mainly the esophagus and cardiac 
stomach [Durbec et al. 1996]. Vagal-derived progenitors of the ENS, which give rise to the 
majority of neurons and glia of the enteric ganglia, enter the foregut mesenchyme and migrate 
in an anteroposterior direction, colonising the entire length of the gut [Taraviras et al. 1999]. 
Studies conducted on mouse embryos have suggested that the enteric component of the vagal 
neural crest generates two distinct lineages: first the sympathoenteric lineage which 
contributes to the formation of the enteric ganglia throughout the entire length of the gut and 
the ganglia of the sympathetic chain, and second the sympathoadrenal lineage, which 
generates progeny that colonise primarily the enteric ganglia of the foregut: esophagus and 
stomach [Durbec et al. 1996]. In addition to the vagal region, neural crest cells emigrating 
from the sacral crest migrate into the gut and contribute to the formation of the postumbilical 
ENS [Pomeranz et al. 1991]. Studies performed on mouse embryos show that initially sacral 
neural crest cells migrate in a caudal to rostral direction and form the ganglia along the dorsal 
part of the hindgut and midgut up to the opening of the bile and pancreatic ducts. Later on the 
neural crest-derived cells enter the hindgut after which their number increases significantly,
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reaching a maximum between ElO-12. The vast majority of the sacral neural crest cells are 
restricted to the coloreetum, whereas far fewer sacral cells are present in the ceca and in the 
postumbilical intestine [Bums et al. 1998].
The fact that the bowel is colonised by cells from only two regions of the neural erest 
raises the possibility that the precursors in these regions might be eommitted to 
enteric lineages. Many experiments, however, indicate that it is unlikely that either 
vagal or sacral crest cells are committed to be enteric neurons or glial cells before 
they leave the neural erest. Behaviour of cells in quail-chick chimeras suggests 
that the fate of crest-derived eells depends on their loeation in the host embryo rather than on 
the site from which the grafts were obtained. Moreover, within the gut the quail’s crest- 
derived cells, despite their tmncal origin, gave rise to bowel-appropriate neuronal phenotypes, 
which include cholinergic, peptidergic and serotonergic neurons. Serotonergic neurons are not 
formed by tmneal crest-derived cells in situ, which suggests an influenee of the enterie 
mieroenvironment on neural differentiation [Gershon et al. 1992]. The implication of these 
data is that crest-derived cells migrate through embryos along defined pathways, thus even 
cells from the wrong region of the erest will find the gut if placed on a path that leads them 
there. The terminally differentiated phenotype expressed by eells of neural erest origin, 
moreover, is not determined before these cells begin to migrate. Phenotypic expression can be 
thus influenced by signals encountered by erest-derived cells, either along the migration 
pathway, or at the site of terminal differentiation. Among the moleeules having such an effect 
on migrating neuronal precursor cells are neurotrophie factors, shown to play a critical role in 
the formation and development of the ENS [Chalazonitis et al. 1998].
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1.4 Neurotrophie factors
Trophic factors include substances that have effects on cell differentiation, survival, 
phenotypic expression and plasticity, as well as on eell growth, for example neurite extension. 
Neurotrophie factors, a subset of trophic factors acting on neural tissue have been defined in 
many ways, from very restrietive to general. Restrictive definitions are based on the research 
conducted on nerve growth factor, and include only the specific aspects of the developmental 
events, such as cell survival and neurite extension. This restrictive definition of a neurotrophie 
substance parallels the restrietive definition of and requirements for a neurotransmitter, which 
were based on experimental paradigms developed for acetylocholine. As more putative 
neurotransmitters and neurotrophie factors have been discovered and analysed, it has beeome 
clear that broader definitions of each group are neeessary to capture the range of aetions of 
these neuromessengers. One of the modem definitions of neurotrophie factors describes them 
as endogenous, soluble proteins regulating survival, growth, morphologieal plasticity or 
synthesis of proteins for differentiated functions of neurons. This definition eombines aspects 
of a functional and physical nature and is compatible with the view that growth faetors are 
multifunctional [Loughin et al. 1993]. Neurotrophie factors perform diverse functions in both 
the developing and mature nervous system, ranging from promoting sur\dval and 
differentiation to regulation of neuronal phenotype and maintenance of mature neurons 
[Chalazonitis et al. 1996 and 1994, Cowen et al. 1998]. Many neurotrophie factors have been 
shown to influence enterie neurons, most of them belong to one of three main families: the 
neurotrophins, the glial cell-line derived neurotrophie factors (GDNF) family and the 
neuropoietic cytokines.
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1.4.1 The GDNF family of neurotrophie factors
Glial cell line-derived neurotrophie factor (GDNF), and the related factors neurturin (NTN), 
artemin (ART), and the recently identified member of this family, persephin (PSP), form the 
GDNF family of neurotrophie faetors. They form a subgroup in the transforming growth 
faetor-p (TGF-p) superfamily. These faetors are basic, dimeric, secretory proteins that share 
cysteine knot structure. GDNF, first identified as a trophic factor for midbrain dopaminergic 
neurons, promotes the survival of many types of neurons including subpopulations of 
peripheral autonomic and sensory, as well as central motor, dopaminergic and noradrenergic 
neurons [Henderson et al. 1994, Tomac et al. 1995]. NTN was cloned as a survival factor for 
sympathetic neurons, after which ART and PSP could be identified on the basis of sequence 
homology. NTN and ART have many neurotrophie effects similar to GDNF, they all support 
survival of peripheral sympathetic and sensory neurons as well as midbrain dopamine neurons. 
PSP is expressed at low levels in most tissues and supports central nervous system 
dopaminergic and motor neurons, but not peripheral neurons [Milbrandt et al. 1998].
All members of the GDNF family employ the c-Ret receptor to initiate signalling cascades, c- 
Ret was originally identified as an oncogene activated by DNA rearrangement, causing human 
papillary thyroid carcinoma, endocrine neoplasia and Hischsprung’s disease [Carlson et al. 
1994, Romeo et al. 1994]. The RET proto oncogene encodes a receptor tyrosine kinase with a 
cadherin related motif and a cysteine rich domain in the extracellular domain (Fig. 1.3). Three 
c-Ret isoforms of different length, generated by alternative splicing of the 3’ region have been 
cloned so far [Lee et al. 2003]. In rodent embryonic and adult tissues, c-Ret is highly 
expressed in peripheral enteric, sympathetic and sensory neurons as well as central motor, 
dopaminergic and noradrenergic neurons [Tsuzuki et al. 1995]. In addition to the nervous
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system, c-Ret expression has been reported in the excretory system such as mesonephric duct 
and branching ureteric bud during embryogenesis. In addition to the c-Ret receptor complex 
necessary to initiate signalling, ligand binding also requires a GPl-anchored component,
GFR a  which is a GDNF-family coreceptor. Four GFRa coreceptors have been identified to 
date. All four known GDNF family members have their own preferred eoreceptor. GFRa-1 
shows specificity towards GDNF, GFRa-2 preferentially binds NTN while GFRa-3 binds 
ART. The PSP receptor, GFRa-4 has been found only in chicken. The sequence of GFRa-4 
shows more similarity to GFRa-1 and GFRa-2 than to GFRa-3 [Ariaksinen et al. 1999]. 
Although coreceptors show preferential binding to their ligands, alternative ligand-receptor 
binding has been shown to occur, for example GDNF can bind to GFRa-2 and GFRa-3 in the 
presence of c-Ret, and ART and NTN can bind to GFRa-1 (Fig. 1.4) [Baloh et al. 1997, Jing 
et al. 1997]. Expression patterns of both GDNF and c-Ret suggest that they could
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Figure 1.3 Schematic representation o f the domains o f Ret receptor tyrosine kinase.
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be involved in the development of the ENS, and this has been confirmed by experiments using 
GDNF/c-Ret knockout mice. These animals showed lack of enteric neurons as well as renal 
agenesis or dysgenesis, causing death soon after birth. A similar phenotype has been observed 
in GFRa-1 knockouts. [Durbee et al. 1996]. In contrast to the lethal phenotype of GFNF and 
GFRa-1 mutants, mice lacking NTN or GFRa-2 are born normally, and show no 
developmental abnormalities. However, the ENS in these animals exhibits a decreased plexus 
density, which correlates with functional deficit in contractile rhythm and activity [Rossi et al. 
1999]. Considering the fact that GFRa-2 expression is weak in the embryonic bowel and 
peaks several weeks after birth [Golden et al. 1999] which is the reverse of the expression 
pattern of GFRa-1, it seems likely that NTN/ GFRa-2 signalling is important for later 
developmental events, and for the maintenance of the mature ENS.
Ret
GFRai GFRC(4
Figure 1.4 The GDNF family o f neurotrophie factors and their preferred receptors. Also shown are possible 
alternative ligand/receptor interaction.
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1.4.2 Neurotrophins
Nerve growth factor (NGF) was the first identified member of the neurotrophin family, 
discovered as early as the 1940’s [Levi-Montaleini et al. 1995]. The second member of the 
neurotrophin family, brain derived neurotrophie factor (BDNF) was discovered forty years 
later, in the 1980's, with the cloning of the remaining molecules belonging to this family, NT- 
3 and NT-4/5 soon after [Bothwell et al. 1995]. All neurotrophins are small, basic proteins, 
active as non covalently linked dimers. Neurotrophins are secretory proteins, with cleavable 
leader sequences, followed by a pro-sequence. Cleavage of the pro-sequence at the consensus 
site common for all neurotrophins yields the biologically active moleeules. All members of 
neurotrophin family share about 50% protein sequence homology, including 6 cysteine 
residues necessary for proper folding of the mature protein (Fig. 1.5). With the exception of 
the NT-4/5, neurotrophins are highly conserved between species.
Figure 1.5 Ribbon model o f the structure o f NGF protein monomer.
Neurotrophins bind to two types of receptors, trks and p75. Trk receptors are transmembrane 
tyrosine kinase receptors that bind specific members of the neurotrophin family. The first
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discovered was trk A, observed as a transforming oncogene in colon carcinoma [Martin et al. 
1986].
The trk family members are highly related, particularly within their tyrosine kinase domains. 
Each of the mammalian trk family members has a signal peptide of about 32 amino acids, a 
glycosylated extracellular domain, a single short transmembrane domain and an intracellular 
domain containing tyrosine kinase activity. Molecular and biochemical analyses have revealed 
the presence of alternative splice variants of the trks. Of these the most prevalent are truncated 
forms of trk B and trk C, which are expressed at high levels in the mature brain [Middlemas et 
al. 1991]. These truncations are intracellular and include the kinase domain, rendering the 
receptors non-functional with respect to tyrosine kinase activity. Trk receptors show specific 
binding of respective members of neurotrophins, trk A preferentially binds NGF, trk B BDNF 
and NT-4/5, while trk C shows speeificity towards NT-3.
In addition to the trk tyrosine kinase receptors which show differences in specificity for 
particular neurotrophins, the p75 receptor binds all members of the neurotrophin family [Chao 
et al. 1994]. p75 is a transmembrane glycoprotein belonging to the TNF/Fas/CD40 
superfamily of receptors. Specific conserved structural elements of this receptor family shared 
by p75 include cysteine rich repeats in the extracellular domain, containing the binding site for 
NGF [Yan et al. 1991], and an intracellular death domain [Liepnish et al. 1997]. No 
alternatively spliced forms of p75 mRNA have been detected, however a soluble form of p75 
capable of binding neurotrophins has been described [Zupan et al. 1989].
p75 can interact with the different Trk reeeptors to modulate neurotrophin actions. For 
example coexpression of p75 with Trk A increases high affinity binding of NGF and
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influences the ability of NGF to stimulate Trk A autophosphorylation in PCI 2 cells [Barker et 
al. 1994]. Experiments involving use of antisense nucleotides against p75 and p75 null mice 
demonstrate that peripheral sympathetic and sensory neurons also display reduced sensitivity 
to NGF without p75 [Davies et al. 1993]. In addition to modifying the binding of 
neurotrophins to Trk receptors, p75 may contribute to the ability of Trk receptors to 
discriminate the preferred ligand from the other neurotrophins. When Trk receptors are 
expressed heterologously in fibroblast cell lines which do not express p75 the responsivity to 
different neurotrophins in less restricted than in neurons, for example NIH 3T3 cells 
expressing Trk A respond to NT3 as well as NGF, but in PC 12 cells and neurons expressing 
p75 as well as Trk A the response was restricted to NGF [Ip et al. 1993]. When p75 levels 
were lowered in PC 12 cells they were increasingly responsive to NT-3, confirming the role of 
p75 in restricting ligand specificity. In addition to the ability to modulate the function of Trk 
receptors, p75 can also initiate cell death when expressed in the absence of Trk’s. In neuronal 
cell lines expression of p75, in the absence of a coexpressed Trk receptor has been shown to 
mediate induction of cell death by NGF [Rabizadeh et al. 1993]. Similarly in primary 
sympathetic neurons which express p75 and Trk A, but not Trk B, BDNF treatment leads to 
apoptosis, indicating that interaction of a neurotrophin with p75 in the absence of Trk 
signalling leads to cell death [Lee et al. 2001].
Mice null for NGF or its receptor, TrkA, as well as brain derived neurotrophie factor (BDNF) 
showed no losses in populations of CNS neurons. Part of the reason for that might be much 
more redundant support received by CNS neurons, due to their more numerous connections. 
However, the role of neurotrophins in the development of the ENS is much more pronounced. 
Members of the neurotrophin family, in particular NT-3 have been demonstrated to play a role 
in the development of enteric neurons and glial cells [Chalazonitis et al. 1996], which is
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suggested by the observation that Trk C, the receptor specific for NT-3 is expressed by crest 
derived cells isolated from the fetal bowel [Chalazonitis et al. 1994]. However, NT-3 is most 
likely not the only factor acting during the development of the ENS, as demonstrated by the 
use of transgenic mice null for NT-3 or Trk C, where most of the neuronal structures 
expressing these genes has shown no abnormalities [Klein et al. 1994].
1.4.3 Neuropoietic cytokines
The amino acid sequences of rat, rabbit and human CNTF show the features of a cytosolic 
protein with no signal peptide, no consensus sequences for glycosylation and only one free 
cysteine residue at position 17. Because of that, it is not secreted but found in the cytoplasm of 
the cells such as astrocytes and schwann cells [Rende et al. 1991, Rudge et al. 1992]. CNTF 
was initially identified by its ability to support the survival of parasympathetic neurons of the 
chick ciliary ganglion in vitro [Adler et al. 1979]. CNTF is structurally and functionally 
related to members of a family of cytokines that include leukemia inhibitory factor (LIF), 
interleukin 6 (lL-6), interleukin 11 (lL-11) and oncostatin M (OSM). CNTF was predicted to 
share common structural characteristics of most of these cytokines, which comprises a four 
helix bundle. Elucidation of the CNTF receptor structure supports the notion that CNTF is 
related to LIF, lL-6 and OSM, due to the fact that all four of these cytokines share the use of 
similar receptor components, that is LlFRp and gp 130 [Davis et al. 1993]. Some of these 
factors, including CNTF also require a specificity determining a  receptor component (Fig.
1.6). The CNTF a  component (CNTFR a) is homologous to the a  component used by lL-6, 
but in contrast to lL-6Ra CNTFR a  is generally restricted to the nervous system in its
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expression, thus largely limiting the aetions of CNTF to neuronal eells. CNTFR a  is also 
expressed in fetal bowel [Rothman et al. 1994] suggesting it might play a role in the 
development of the ENS, whieh was confirmed by experiments disrupting expression of 
CNTFR a: sueh mutation is lethal and miee carrying it die soon after birth due to the lack of 
enteric motor neurons [Gershon et al. 1997, Li et al. 1995]. In addition, mice with targeted 
mutations that disrupt expression of LIFR p also die shortly after birth [DeChiara et al. 1995]. 
Since the ENS has not been found to be abnormal in animals that lack CNTF or LIF, it is 
likely that the bowel expresses a ligand other than CNTF that is capable of activating the 
CNTF receptor complex by binding to CNTFR a  [Li et al. 1995].
I
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Figure 1.6 Formation o f the CNTF signalling complex. First step requires binding o f CNTF to its specific 
receptor, CNTFRa, which then binds to gpl30, and finally to LIFR(3 receptors, which initiates the signalling 
cascade.
Even though CNTF and LIF may not be essential for the development of the ENS, their ability 
to activate the CNTF receptor complex makes it possible to use these ligands to analyse the 
role of the tripartite CNTF receptor in the development of enterie neurons and glia [Ip et al.
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1992]. Research on the role of ciliary neurotrophie factor (CNTF) has shown that 
administration of CNTF increases the survival of hippocampal neurons in vitro [Ip et al. 
1991]; it also prevents degeneration of dopaminergic neurons in CNS [Hagg et al. 1993].
There is evidence suggesting that neuropoietic cytokines collaborate with NT-3 in the 
development of at least a subset of enteric neurons. The progenitors that colonize the bowel 
below the rostral foregut depend for their survival and subsequent development upon 
activation of the c-Ret receptor complex by GDNF (Fig. 1.7) [Trupp et al. 1996].
Two distinct lineages of neurons arise from the early GDNF/c-Ret dependent precursors. One 
of these is transiently catecholaminergic and dependent on expression of the mash-1 
(mammalian homologue of achaete-scute complex) gene, which promotes differentiation of 
neuronal precursor cells [Guilemot et al. 1993]. This lineage shares properties of 
sympathoadrenal precursors and is bom early, giving rise to all of serotonergic neurons of the 
ENS [Blaugrund etal. 1996].
Both NT-3 and CNTF/LIF have been demonstrated to affect the in vitro development of 
sympathoadrenal cells [Patterson et al. 1992]. Moreover, the effects of cytokines on 
sympathoadrenal cells are modified when they are applied in combination with a neurotrophin 
[Ip et al. 1994]. Except their effects on developing neurons, neurotrophie factors are also 
known to participate in the maintenance and protection of adult and aging neuronal 
populations.
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The most common free radicals produced in mitochondria include superoxide anions, 
hydrogen peroxide and hydroxyl radicals. Many cellular components are suseeptible to free 
radical damage, these inelude eellular membranes. For example, free radicals react with 
polyunsaturated fatty acids to form lipid peroxides whieh in turn decompose to give rise, in 
several reactions, to mutagenic malondialdehyde [Lippman et al. 1983]. Lipid peroxides have 
been shown to produce an irreversible impairment of membrane fluidity and elastieity, which 
could lead to rupture of cells. Such changes are likely to have most significant effects on post 
mitotic cells such as neurons. The breakdown produets of lipid peroxidation are also belived to 
contribute to the production of lipofuscin, a brown pigment that aecumulates with age and 
which appears to correlate with the age of animal cells. Again, the build up of lipofuscin is 
particularly noticeable in postmitotic cells and it has been shown that by the age of 90 years up 
to 7% of the intraeellular volume of a human myoeardial cell may be occupied by this pigment 
[Brody et al. 1995]. Free radical activity has also been shown to oxidise and cross link proteins 
including enzymes and connective tissue. In fact, oxidised proteins in an old animal may 
represent up to 50% of the total cellular protein eontent and this is likely to be a major reason 
for the observed drop in catalytic activity of many enzymes correlated with age [Stadtman et 
al. 1995]. Another type of molecule that is highly susceptible to free radical damage is DNA. 
Most common effects of free radicals on nucleic acids include base deletion and strand 
breakage. Although repair systems correet most of the damage, oxidative DNA lesions 
nevertheless accumulate with age especially at the later stages of life due to the lowered 
efficiency of DNA repair systems [Rao et al. 1994, Chen et al. 2002], contributing to the aging 
process.
The organelles by far most affected by free radical damage are mitochondria. While they use 
about 90% of the total amount of oxygen consumed by the cell, their genetic material,
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unprotected by histones is highly susceptible to free radical damage. That and the fact that 
mitochondrial DNA repair systems are less effective than those present in the nucleus [Bohr et 
al. 2002] results in the far greater number of oxidative lesions occurring to the mitochondrial 
DNA, about ten times more than to nuclear DNA.
The rate at which mitochondrial DNA accumulates damage is also mueh faster than in the 
nucleus, especially in postmitotic cells [Bhaskar et al. 2000]. As a consequence, ATP 
production and mitochondrial turnover gradually decreases during the life of the cell. It has 
also been demonstrated that the mitochondria of older animals produce significantly higher 
levels of reactive oxygen species than these of younger animals [Ross et al. 2000]. Thus, it can 
be hypothesised that in an escalating process, damaged mitochondria leak more free radicals, 
contributing to the inereasing amount of damage to the eell and themselves. As an outeome, 
one might hypothesise that energy available to the cell would be depleted, and tissues would 
degenerate, which indeed is the case in aged animals.
The only way to slow down the onset of age associated changes demonstrated so far is caloric 
restriction: the reduction of food intake without loss of essential nutrients and minerals. This 
was first shown by MeCay [McCay et al. 1935], who reared rats on a diet that reduced the 
amount of calories by about 30% compared to ad libitum fed animals. The results showed that 
males introduced to this diet two weeks after weaning experienced a significant extension of 
mean life span compared to eontrols. Maximum life span was also significantly increased with 
the longest lived calorieally restrieted rat living for 1465 days compared to 969 days for the 
oldest control. Another striking feature was the healthy demeanour of the caloric restricted 
rats. At the age of 1000 days, at which point all the control animals had died, the calorieally
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restricted rats were still highly active and displayed the morphology of much younger animals. 
Despite its importance, the mechanisms underlying the anti-aging effects of caloric reduction 
are still poorly understood. One proposal has been that food restriction retards ageing by 
slowing down the basal metabolic rate [McCarter et al. 1985]. However, this theory has not 
gained much support. For example, direct measurements of oxygen intake over 24 hours 
period has demonstrated that food restriction does not decrease the basal metabolic rate per 
unit of body mass [MeCarter et al. 1985]. Examination of food intake records over the life 
span leads to a similar conclusion and if anything shows that the total lifetime consumption of 
calories in underfed animals is greater than normal [Masoro et al. 1991]. A more convincing 
metabolic explanation is that food restriction causes a major reorganisation of energy 
utilisation [Feuers et al. 1995]. For example, food deprivation has been shown to produce a 
lowering of average body temperature and a shift away from fat production towards glucose 
synthesis. It has also been found that calorieally restricted animals have a normal metabolic 
rate prior to feeding but a higher one just after eating. In addition, a wide range of enzymes is 
altered by dietary restriction including those in the liver participating in the drug metabolism 
and elimination, as well as energy metabolism [Hagopian et al. 2002]. There is eonsiderable 
evidenee however to support the idea that dietary restrietion might be acting to reduce the 
formation of free radicals. For example, it has been shown that age-related reductions in the 
antioxidant enzymes are partially prevented by dietary restriction, and this is also 
accompanied by lower levels of superoxide and hydroxyl radicals along with decreased lipid 
peroxidation of liver mitochondrial and microsomal membranes [Rao et al. 1990]. This may 
be, in part under genetic control as reduced food intake modulates the expression of a wide 
range of genes including those eontrolling antioxidant enzymes [Rao et al. 1990].
Additionally, food restriction protects against the age-related decline of mitochondria to 
oxidise malondialdehyde, which is a highly potent souree of free radicals.
40
In conclusion, increased antioxidant defence systems eoupled with lower production of free 
radicals is likely to be the mechanism by which caloric restriction exerts its effects.
1.6 Age-related changes in the enteric nervous system
There is compelling evidence for an increased incidenee of gastrointestinal tract disorders with 
advanced age [Bannister et al. 1987, Madsen et al. 1992]. It has been reported that the rate of 
colonic transit is slowed in elderly humans [Madsen et al. 1992], a similar finding has also 
been made in old rats [McDougal et al. 1984]. An age-related reduction in both frequency and 
amplitude of the peristaltic wave has also been reported in elderly patients [Horowitz et al. 
1984], as well as decrease in digestion and absorption of food and immune function. Since the 
ENS is responsible for coordinating and integrating the motility of the gut, it has been 
extensively studied in order to establish its role in the motility disorders in the elderly [Gomes 
et al. 1997]. In contrast to neurons in other autonomic nerve groups, quantitative studies of cell 
numbers within the myenteric plexus have consistently demonstrated extensive losses in the 
oesophagus, small and large intestine of old guinea pigs and rats [Gabella et al. 1989, Santer et 
al. 1988]. The submucosal plexus is affected by age in similar manner, as was shown by the 
neuronal loss in aged compared to young mice [El-Salhy et al. 1999] although the number of 
ganglia present in the submucous plexus did not deerease [El-Salhy et al. 1999]. Age- 
dependent changes in the intestine are not restricted to neuronal numbers. Isolated organ bath 
experiments on segments of intestine taken from aged rats have revealed signifieant reduction 
in the cholinergic component of neuromuscular transmission [Nowak et al. 1990].
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Immunohistochemical studies have demonstrated a reduced density of peptidergic fibres in the 
gastrointestinal tract of aged rats [Barker et al. 1991]. The density of extrinsic fibres to the 
myenteric plexus, projecting from the coeliac superior mesenteric ganglion and containing 
noradrenaline also signifieantly declines with age [Barker et al. 1991]. Reports concerning age 
dependent changes in the activity of antioxidant enzymes in the gastrointestinal tract are 
somewhat contradictory and vary from study to study, however it was found that aetivities of 
at least some of the antioxidant enzymes are decreased in aged animals [Xia et al. 1995] In 
general, most of the overall changes observed in the ENS during aging stems from the gradual 
loss of neurons, or at least some their populations. In multieellular organisms, the aging 
process is usually characterized by a decline of function and increased rate of pathological 
conditions. To identify the molecular events associated with aging in mammals, several 
laboratories have used the mieroarray expression analysis. To date, these studies have 
provided insight into global, age-associated ehanges in gene expression in mouse skeletal 
musele, human skin fibroblasts and mouse liver [Lee et al. 2000, Han et al. 2000], as well as 
duodenum and colon in rats. What is interesting, is that the data reveal few similarities in the 
age associated ehanges in gene expression patterns among these tissues which suggests that 
different mechanisms may underlie the aging process in different cell types. This observation 
highlights the complexity and intricaey of aging proeess, as well as its dependence on the 
particular cellular background.
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1.7 Aims
Neurotrophie faetors have been shown to reduce free radical production in the neurons in vitro 
[Dougan et al. 1997] (T.Cowen, personal communication), possibly by affecting the 
antioxidant enzymes present in the cells. For that reason, neurotrophie factors might be useful 
in counteracting gradual decline in numbers of enteric ganglion cells oceurring with age, 
espeeially since ROS induced damage to the cellular components has been implicated in this 
process.
Considering these facts, it is possible that neurotrophie factors participate in the mechanisms 
evoked by calorie restriction, which result in reduced free radical damage, and extend the life 
span of enteric ganglion cells.
This study was undertaken in order to investigate the possible roles of NT-3 and GDNF in the 
survival of enterie ganglion cells exposed to free radical damage. The effects of these factors 
on cultured enteric ganglia are deseribed in first chapter, the seeond chapter focuses on the 
possible effects of NT-3 and GDNF on the protein levels of antioxidant enzymes. The final 
chapter examines signalling cascades underlying the effects NT-3 described in the previous 
chapters.
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Chapter 2
Materials and Methods
44
2.1 Primary cultures of enteric ganglion calls and factor treatment
Enteric ganglion cell cultures were prepared described in [Saffrey et al. 2000]. Briefly, small 
intestines of 7 day old Sprague-Dawley rats were harvested and placed in Hanks balanced salt 
solution (HBSS, Sigma) containing gentamycin and metronidazole. After removing the 
mesentery, the muscularis externa with embedded enteric ganglion cells was separated by 
peeling from the rest of the gut and incubated for 30 minutes in collagenase type II (1 mg/ml in 
HBSS containing 10 pg/ml DNase) at 37°C. Subsequently the tissue was vortexed and 
incubated with fresh enzyme for another 30 minutes. Freed pieces of plexus were collected 
under a dissecting microscope, plaeed in trypsin-EDTA solution (Sigma), incubated for 15 
minutes and dispersed by passage through a 25 gauge needle to obtain a single cell suspension. 
Cells were seeded in 150 |il of 199 medium with N1 supplements (N 199, Sigma) containing 
10% fetal calf serum (ECS, Sigma) at 2 X 10"* cells per 13mm diameter glass coverslip coated 
with poly L lysine. After 1 hour incubation at 37°C, 2.5 % CO2 a further 850 gl of 199 N1 
medium without FCS was added. Cultures designed for preparation of cell lysates 
subsequently used in western blots were seeded in 1ml of 199 medium with N 1 supplements 
and FCS at 7 X 10  ^cells per 30mm diameter glass coverslip, covered with poly L lysine; after 
1 hour incubation medium was replaced with 2 ml of 199 medium with N1 supplements 
without FCS. 16 hours later medium was removed and replaced with serum-free 199 N l. Cells 
were supplemented with desired concentrations of appropriate factors 24 hours after plating.
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2.2 Hydrogen peroxide exposure
Dilutions of hydrogen peroxide (Sigma) were made fresh from 30% stock solution into HBSS 
prior to each experiment. Cultures of enteric ganglion cells incubated with NT-3 or GDNF 
were exposed to the desired concentrations of H2O2 , and subsequently ineubated prior to the 
cell viability assay for 6 hours (MTS assay) or 4 hours (Bis-benzimide/propidium iodide 
staining) at 37°C, 2.5% CO2 .
2.3 MTS viability assay
Viability of the cells exposed to H2O2 was assayed using the CellTiter96^ kit (Promega).
Assay is based on a conversion of tétrazolium compound by mitochondrial enzymes to 
formazan, absorbing at 490nm. The absorbanee values obtained in this assay correspond to the 
number of live mitochondria, and indirectly the number of live cells present in the cultures. In 
the experimental design used in this work the number of cells was constant in each 
experiment, which allows relating the absorbance values obtained in the assay to the number 
of viable cells in the cultures. Assay was performed as follows: 6 hours after exposure to 
H2O2 , the growth medium of the cultures was replaced with HBSS without phenol red 
(Sigma), and MTS reagent was added. After 4 hours incubation at 37°C supernatants were 
eollected, and their absorbanee was measured at 492 nm. Experiments were repeated 3 times; 
at least 4-6 replieate treatments were used for eaeh eondition, in each experiment.
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2.4 Immunohistochemistrv and cell viability stain
2.4.1 PGP 9.5 immunolabelling
PGP 9.5 is a specific marker of neuronal cells, used in immunolabelling techniques to 
visualize neurons. In the experiments performed in this work, PGP 9.5 immunolabelling was 
employed to allow clear distinction between neurons and glial cells during cell counting.
PGP 9.5 immunolabelling was performed as follows: cell cultures grown for the designed 
period of time were washed with phosphate buffered saline (PBS, pH 7.3) and fixed with 4% 
paraformaldehyde for 1 hour at room temperature. Fixed cultures were washed with PBS and 
incubated with primary rabbit anti PGP 9.5 antibody (1:30000 in antibody diluting solution 
(ABDS: PBS, lysine, 0.1% sodium azide, 0.1% BSA, 1% Triton X-100) for 2 hours at room 
temperature, washed with PBS and incubated with secondary goat anti-rabbit antibody 
conjugated with fluorescein (1:100 in ABDS) for one hour at room temperature. After 
incubation cultures were washed with PBS and mounted on glass slides in Citifluor mountant.
2.4.2 Bis-benzimide/propidium iodide staining
4 hours after exposure to H2O2 the eulture medium was removed and replaced with 1ml of 
fresh medium. lOgl of bis-benzimide (Hoeehst stain) (stock 500gg/ml in PBS) was added to 
each well. After 20 minutes incubation at 37°C lOgl of propidium iodide (PI) was added and 
cultures were ineubated at room temperature for 5 minutes. Subsequently all wells were
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washed two times with HBSS without phenol red (Sigma), fixed fori hour in 4% 
glutaraldehyde, washed twice in PBS and mounted on glass slides in Citifluor mountant.
2.4.3 Catalase/SOD Cu/Zn immunolabelling
Cultures fixed as deseribed above were blocked for one hour with mixed 5% donkey and 
rabbit sera in PBS, and subsequently ineubated with polyelonal rabbit anti-catalase antibody 
(diluted 1:500 in ABDS) for 6 hours at room temperature. After incubation cells were washed 
with PBS and ineubated overnight at 4°C with sheep polyclonal antibody against superoxide 
dismutase Cu/Zn (diluted 1:500 in ABDS). Cultures with bound primary antibodies were 
washed again with PBS, and incubated for 1 hour at room temperature with the donkey anti 
rabbit secondary antibody conjugated with fluorescein (1:100 in ABDS) washed with PBS and 
incubated with polyclonal anti sheep seeondary antibody conjugated with rhodamine red for 
two hours at room temperature (diluted 1:100 in ABDS). Stained eultures were mounted on 
glass slides in Citifluor and viewed under X400 magnification using Zeiss Axiophot 
microscope. Specificity of secondary antibodies was confirmed by immunolabelling of 
cultures with omission of primary antibodies; both secondary antibodies failed to immunolabel 
the eultures without pretreatment with respective primary antibodies.
2.5 Quantification of cell numbers
Cells stained with PGP 9.5 or bis-benzimide and propidium iodide were counted under 400 X 
magnification using either Zeiss Axiophot or Nikon Eclipse EB800 microscope. Bis-
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benzimide and propidium iodide stained cells were counted in five random fields of view on 
each coverslip, while PGP 9.5 stained eells were counted in a strip across the diameter of the 
coverslip. Data were obtained from three experiments and pooled for subsequent statistical 
analysis.
2.6 PI-3K inhibition
2.6.1 Preparation of cell cultures
Cell cultures prepared as described above were allowed to grow for 24 hours after seeding. 
NT-3 and GDNF were then added to the cultures at lOng/ml concentration. Where 
appropriate, the specific inhibitor of PI-3 kinase, LY 294002 at constant concentration of 300 
pM was added to the cells 30 minutes prior to factor treatment. Subsequently cells were grown 
for 12 or 36 hours at 37°C, 2.5 % CO2, fixed in 4% paraformaldehyde for 1 hours at room 
temperature and processed for PGP 9.5 immunostaining or stored at +4°C for further use, 
storage time did not exceed 7 days.
2.6.2 Preparation of cell lysates
For obtaining cell lysates, cultures of enterie ganglion cells were grown for 24 hours after 
seeding, and where appropriate treated with LY 294002 inhibitor at a concentration of 300pM 
concentration. 30 minutes later cells received NT-3 at lOng/ml concentration. Cells were 
collected on ice 5, 20, 35 and 55 minutes after NT-3 treatment, washed three times with cold
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PBS and scraped into NP40 lysis buffer (PBS, 1%NP40 detergent, NaCl, Tris pH 8.0, protease 
inhibitor coektail (Boeringer). Subsequently cells were incubated on ice for 30 minutes and 
spun at 10000 rpm, 4°C for 10 minutes and supernatants were collected and stored at -20°C 
for protein quantification. Average protein yield per one condition was 0.7mg/ml.
2.7 Western blot analysis
After 12 or 36 hours incubation with factors (NT-3 or GDNF at lOng/ml concentration) 
protein lysates from the cultures were prepared in the same way as described above and stored 
at -20°C. Protein assay was performed using Bio Rad protein assay kit, according to 
manufacturer’s protocol. Standard curves were prepared for each session of protein 
determination from known quantities of bovine serum albumin (Sigma).
Protein lysates obtained fi'om the cultures were processed as follows.
Desired amount of samples was loaded onto 15% SDS-PAGE gels. Proteins were separated in 
electrode buffer (25mM Tris, 192mM glycine, 0.1% SDS) at 120V for 
3 hours and transferred to nitrocellulose membranes by electroblotting in transfer buffer 
(25mM Tris, 192mM glycine, 0.1% SDS, 20% methanol) at lOOV for one hour. Equal protein 
loading was checked after electrob lotting by incubating membranes containing transferred 
proteins with ponceau red (Sigma), which allowed visual detection of the proteins present on 
the membranes.
To obtain an estimate of the amount of catalase and SOD Cu/Zn detected on the membranes, 
and also to eheek the sensitivity of assay, standard curves were prepared using from 50 to 
800ng of purified eatalase or SOD Cu/Zn protein (Sigma).
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Membranes were blocked in PLT (PBS, 5% non fat dry milk, 0.1% Tween 20) overnight at 
4°C, and processed for immunoblotting as described above.
Briefly, blots were incubated with primary antibodies (see table 2.1), diluted in PLT for two 
hours at room temperature, washed three times, 10 minutes each time with PLT and incubated 
with secondary antibodies conjugated with horseradish peroxidase for one hour at room 
temperature with two subsequent washes in PBS containing 1% Tween 20 and a final 10 
minutes wash with PBS. Blots were developed using chemiluminescence kit (Amersham). 
Exposed films were processed on an automated Kodak X-OMAT processor and digitised 
using alpha imager software; optical density was measured using Scion Image software (Scion 
Corporation).
Densitometry was used in order examine the differences between bands obtained in western 
blots. Briefly, a diagonal strip across the image of western blot membrane, containing the 
bands was selected. Subsequently, software package measured intensity of bands and prepared 
a densitometric graph with peaks which area depends on the intensity of bands. Optical 
density (CD) values, corresponding to the areas under peaks were then gathered from several 
western blot membranes and used to calculate mean CD value of a band obtained for a given 
protein.
Before reprobing, each membrane was incubated in stripping buffer (O.IM glycine, O.IM Tris- 
HCl, pH 2.0) for 15 minutes at room temperature, washed in neutralizing buffer (Tris-HCl pH 
8.8) and blocked in PLT for one hour at room temperature.
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Primary and 
secondary antibodies 
used for immunoblotting
Supplier Dilution
Anti Catalase Calbiochem 1:2000
Anti SOD Cu\Zn Calbiochem 1:2000
Anti bel 2 Oncogene 1:1000
Anti c-fos Oncogene 1:1000
Anti ERK2 Calbiochem 1:1000
Anti phospho ERK Calbiochem 1:2500
Anti phospho MEP 1/2 Sigma 1:1000
Anti phospho Akt Santa Cruz 1:500
Secondary antibodies
(conjugated with horseradish peroxidase)
Donkey anti sheep Sigma 1:5000
Goat anti rabbit Pierce 1:5000
Table 2.1 Antibodies and their concentrations used in this work.
2.8 Statistical analysis
Data obtained in the experiments was analysed by one-way analysis of variance (ANOVA), at 
p < 0.05 using Origin software package.
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Chapter 3
The effects of neurotrophic factors on cultured 
enteric ganglion cells subjected to H2O2 induced 
oxidative stress
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Summary
The experiments described in this chapter were undertaken in order to elucidate the effects of 
NT-3 and GDNF on the survival of enteric ganglion cells exposed to oxidative stress in vitro. 
Hydrogen peroxide (H2O2) exposure is a well-established way of inducing oxidative stress that 
has been used in a variety of experimental models [Fuson et al. 1999, Mishel et al. 1997] 
therefore it was chosen as the means of inducing oxidative stress in these experiments. To test 
the potential of H2O2 to induce cell death in enteric ganglion cells, cultured enteric ganglia 
were exposed to a range of H2O2 concentrations for 6 hours, followed by measurement of cell 
viability using MTS assay. As expected, H2O2 decreased cell viability in a dose dependent 
manner.
Next, effects of NT-3 and GDNF on the viability of cells exposed to H2O2 were assessed. NT- 
3 showed a slight protective effect which, although only bordering on significance was 
observed at every concentration of H2O2 . In contrast, GDNF did not increase the viability of 
cells exposed to oxidative stress. In order to investigate the possible differential effect of H2O2 
treatment on the neuronal and glial populations, cultures of enteric ganglia were exposed to 
H2O2 and subsequently immunolabelled with a pan neuronal marker, PGP 9.5. Cell counts 
confirmed the results of MTS assay, showing a decline in both neuronal and glial cell numbers 
with increasing concentrations of H2O2, also indicating that neurons are more vulnerable to 
oxidative stress than glial cells.
In order to study the effects of NT-3 and GDNF on H2O2 treated cultures more closely, 
cultures exposed to H2O2 for 4 hours were stained with Hoechst and propidium iodide dyes, 
allowing distinction between live and dead cells. Cell counts performed on stained cultures
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confirmed the MTS data. NT-3 decreased the number of dead cells present in both H2O2 
treated and control cultures. GDNF did not have a significant effect on the numbers of 
propidium iodide stained cells. Instead, it increased total number of cells in the control 
cultures. However, H2O2 treatment abolished that effect. Interestingly, cell viability in cultures 
that received mixed NT-3 and GDNF treatment was similar to that in cultures that did not 
receive factor treatment. These data suggests that NT-3 might play a role in protecting enteric 
ganglion cells from oxidative stress in vivo.
3. Introduction
Is now well established that neurotrophic factors are crucial for survival of neuronal 
populations during development [Yamamori et al. 1992] and for the maintenance of existing 
neuronal circuitry. Recent evidence, however, shows that neurons are also dependent on 
neurotrophic factor support in another context, that is when they face adverse conditions 
[Heaton et al. 2000, Miyazaki et al. 1999], including oxidative stress. While low levels of free 
radicals are important in cell to cell interactions [Lipton et al. 1997, McCord et al. 1995], it is 
known that high levels of free radicals are damaging. Oxidative stress has been implicated to 
be the cause of neuronal loss in many disorders, and also in aging [Harman et al. 1992]. 
Supporting this idea is the fact that increased oxidative damage has been demonstrated in 
many human neurodegenerative disorders [Coyle et al. 1993]. There is evidence 
demonstrating improved neuronal survival after neurotrophic factor treatment during 
pathological conditions, such as Parkinson's disease [Zum et al. 2001] although the molecular 
mechanisms underlying this effect are still not completely understood.
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Most research so far has concentrated on the CNS. However, there are data indicating that free 
radical damage may also play a role in the decrease of the neuronal numbers observed in the 
ENS during aging [Cowen et al. 2000]. As in the case of the CNS, there is some evidence 
suggesting that neurotrophic factors can protect enteric neurons from oxidative damage. For 
example, it has been shown that NT-3 and GDNF treatment lowers free radical production in 
the rat gut in vitro [Thrasivolou et al. 2000]. Despite the fact that our understanding of both 
signalling pathways and protective mechanisms activated by neurotrophic factors still requires 
more research, it is likely that neurotrophic factors would employ similar mechanisms to 
protect neuronal populations of the CNS and ENS. If that is the case, then data describing 
protective effects of neurotrophic factors in the CNS gathered so far could give valuable clues 
to understanding the effects of neurotrophic factors on ENS neurons.
3.1 Effects of oxidative stress on neuronal populations of the CNS and ENS
As described in the general introduction, (section 1.5), neurons are exposed to attack by free 
radicals throughout their life, resulting in a whole range of deletorious effects.
When exposed to oxidative stress, neurons can die either by necrosis or apoptosis. Apoptosis 
is also called programmed cell death, and involves activation of a cascade of proteins 
participating in the process, as well as synthesis of new proteins required for progression of 
the process. The characteristic morphological features of apoptosis include shrunken nuclei 
with condensed chromatin and autophagic vacuoles in the cytoplasm, as opposed to necrotic 
cell death which involves swelling of the cellular membrane and intracellular organelles, 
eventually leading to spilling of the cellular contents into the surrounding tissue [Banasiak et
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al. 2000]. Most often dying cells do not display characteristics of only one of the two modes of 
death, but rather show morphologies including traits of both apoptosis and necrosis.
Among many other stimuli, incubation of cultured PC 12 cells in a high oxygen atmosphere 
results in their apoptotic cell death, mediated by ROS [Kubo et al. 1996]. Substances that 
increase the ROS content in cells, such as hydrogen peroxide, singlet oxygen and 
peroxynitrate all cause death of neurons in vitro and in vivo by apoptosis or necrosis, 
depending of the severity of the oxidative stress [Hoyt et al. 1997, Ming et al. 2001, Regan et 
al. 2001, Liang et al. 2000]. Neuronal death may also follow downregulation of cellular 
antioxidant systems. After inhibition of cysteine uptake and consequent decrease of 
glutathione synthesis or after exposure to high extracellular levels of glutamate, cultured 
neurons die through a mechanism intermediate between apoptosis and necrosis [Tan et al. 
1998]. Downregulation of superoxide dismutase (SOD) in embryonic spinal neurons and PCI 2 
cells has a similar effect, causing enhancement of the production of ROS and induction of 
apoptosis [Troy et al. 1996].
As mentioned previously, oxidative stress has been implicated in a variety of very different 
human neurodegenerative disorders. Although the specific sources of the free radicals and the 
neuronal populations affected differ between the particular disorders, there are many 
similarities in their effects. Increased levels of oxidatively altered proteins, lipids and nucleic 
acids, accompanied by increased levels of antioxidant enzymes and other stress response 
proteins has been detected in post mortem tissue samples from Parkinson's disease patients 
[Dexter et al. 1986]. Disturbances of mitochondrial metabolism are also common, which 
might contribute to the increased levels of oxidative damage through the leakage of ROS from 
the mitochondrial respiratory chain in Alzheimer's disease [Behl et al. 2002]. These
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observations implicate oxidative stress as a main cause of pathogenesis of such disorders as 
Alzheimer's disease, and are backed up by both histopathological and experimental evidence.
It is known that increased levels of cellular components damaged by ROS appear early 
compared to other pathological changes in these disorders [Pratico et al. 2001]. Post mortem 
analyses of brains from Parkinson's patients have shown an increase of both ferric and total 
iron in the affected brain regions, which could contribute to the production of hydroxyl anion 
from hydrogen peroxide [Dexter et al. 1989]. Aggregates of amyloid (3 (Ap), found in the 
senile plaques as the major symptom of Alzheimer's disease were proved to indirectly and 
directly induce oxidative stress in cells in vitro and in vivo [Behl et al. 1999 and 1994, Mark et 
al. 1997, Keller et al. 1997]. By impairing the function of membrane ion transporters and 
promoting membrane depolarisation Ap induced lipid peroxidation renders neurons vulnerable 
to apoptosis. These processes are thought to be involved in increasing the amount of free 
radicals present in the cells leading to induction of oxidative stress. This view is supported by 
studies showing that antioxidants, such as vitamin E, uric acid, propyl gallate, glutathione and 
estrogens can protect neurons from Ap toxicity [Stull et al. 2002].
Not much is known about the involvement of oxidative stress in the pathologies of the PNS, 
including the ENS, or the changes observed in the ENS during aging. There is some evidence 
however, suggesting that oxidative stress has similar, deletorious effects on the neuronal 
populations of both the ENS and CNS. It has been demonstrated that pretreatment of intestinal 
segments with hydrogen peroxide or cumene hydroperoxide resulted in a damaged contractile 
response of the longitudinal smooth muscle to methacholine in all parts of the G1 tract, and 
diminished maximal response as well as decreased contractions [Van der Vilet et al. 1989]. 
Moreover, due to their location, it can be argued that enteric neurons are at greater risk of 
oxidative injury than neurons of CNS. Ingested food contains substances that can increase free
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radical formation, for example a diet containing excess iron might cause raise in the levels of 
free radicals [Halliwell et al. 1986] especially in the situation where the intestine was iron 
deficient before receiving iron rich diet [Srigirdhar et al. 1998]. Taken together, it is feasible to 
assume that oxidative stress might play a role at least in some ENS disorders, as well as aging.
3.2 Survival promoting effects of neurotrophic factors
As described above, neurotrophic factors are known to promote the survival of neurons at 
different developmental stages, as well as play a role in maintenance and stress resistance of 
adult neuronal cells. A considerable amount of evidence has accumulated over the years to 
support this view, using both in vivo and in vitro models. Protective effects of neurotrophic 
factors on neuronal populations extend beyond developmental changes. Data collected by 
many laboratories supports the view that, in addition to participating in the normal 
development of the nervous system, neurotrophic factors also protect neurons facing adverse 
conditions, such as ischemia or various chemical insults. NGF has been implicated in 
protecting cerebellar granule cells from ethanol toxicity in vitro, possibly by activating the PI3 
kinase signalling pathway [Heaton et al. 2000], while GDNF has been shown to protect rat 
hippocampal neurons in vivo from death after transient ischemia [Miyazaki et al. 1999], as 
well as dopaminergic neurons from 6-hydroxydopamine (6-OHDA) neurotoxicity [Yurek et 
al. 1999].
Many of the conditions causing neuronal death either directly or indirectly affect the redox 
status of the cells, increasing the cellular concentration of free radicals [Hoyt et al. 1997]. 
Considering this fact, it seems likely that neurotrophic factors might protect neurons at least in
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part by increasing their ability to cope with oxidative stress. One possible mechanism by 
which trophic factors increase cellular resistance to free radicals could be by enhancing 
neuronal antioxidant defences [Mattson et al. 1996] and inhibiting neuronal death induced by 
oxidative stress, which has been documented in vitro using cultured neurons [Klocker et al.
1998]. NGF has been demonstrated to protect aged CNS in vivo [Nistico et al. 1992] and PC12 
cells in vitro [Sampath et al. 1994] against free radical damage, possibly by the means of 
diminishing of the intraneuronal free radical concentration [Dougan et al. 1997], although its 
neuroprotective effects do not always employ this mechanism [Satoh et al. 1996]. In addition 
to the possible inhibition of direct oxidative attack by free radicals, neurotrophins may also act 
directly through redox sensitive transcription factors, influencing glutathione redox status, and 
enhancing the expression of antioxidant enzymes in the cell cultures [Mattson et al. 1997].
GDNF has been reported to have antioxidant properties similar to these of neurotrophins. 
When administered into striatum of adult rats, it simultaneously increased the levels of many 
antioxidant enzymes involved in the metabolism of free radicals, which suggests that GDNF 
can maintain balance between antioxidant enzymes in the cell, as well as facilitate efficient 
removal of free radicals [Chao et al. 1999]. GDNF has also been shown to protect 
mesencephalic neurons in vitro from apoptosis induced by oxidative stress, by activating PI3 
kinase and its downstream target, Akt [Sawada et al. 2000].
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3.3 Aims
Neurotrophic factors are known to protect various neuronal populations from cell death 
induced by oxidative stress. However, most research has concentrated on the CNS; there are 
relatively few reports concerning the actions of neurotrophic factors on the neurons of the 
PNS. The aim of the work described in this chapter was to investigate the effects of NT-3 and 
GDNF on cultures of enteric ganglion cells exposed to oxidative stress, using an MTS cell 
viability assay. Cell cultures exposed to oxidative stress were also stained using propidium 
iodide and bis-benzimide (Hoechst stain) in order to examine the effect of oxidative stress and 
factor treatment on both total and dead cell numbers in the cultures. The possible differential 
effects of H2O2 exposure on neurons and glial cells were examined by counting surviving cells 
in the cultures immunostained with PGP 9.5.
3.4 Methods
The methods used in this chapter are described in chapter 2 (sections 2.1, 2.2, 2.3, 2.4.1, 2.4.2 
and 2.5)
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3.5 Results
3.5.1 Assessment of H2O2 toxicity on cultured enteric ganglion cells.
To determine an appropriate range of H2O2 concentrations for those experiments, cultures of 
enteric ganglion cells established as described in materials and methods (see chapter 2, section 
2.1) were allowed to grow for 24 hours after seeding, and subsequently exposed for 6 hours to 
H2O2 at concentrations of 1,5, 10 and 25p.M. Results of three separate experiments are 
summarized in Fig. 3.1. The MTS assay data show a dose-dependent decrease in cell viability 
with increasing levels of H2O2 . The highest concentration of H2O2 eliminated all the cells from 
the culture at the time of viability assay. Therefore, it was not used in further experiments.
The cultures of dissociated myenteric plexus ganglia used in this study contain both neurons 
and glia [Saffrey et al. 2000]. In order to investigate the possible differential effects of H2O2 
on neuronal and glial populations present in the cultures, cells exposed to H2O2 for 6 hours 
were subsequently fixed using paraformaldehyde and immunolabelled with antibody against 
the general neuronal marker PGP 9.5.
Cells in the immunostained cultures were counted as described in materials and methods 
(chapter 2, section 2.5). A summary of the data for cell counts is shown in Table 3.1. Both 
neuronal and glial populations were found to diminish with increasing concentrations of H2O2 , 
confirming the results of the MTS assays.
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Figure 3.1 The effect o f different concentrations ofH^O? on viability o f cultured enteric ganglion cells 
Results are expressed as the percentage o f untreated controls. Data are presented as a mean o f 3 separate 
experiments, each treatment done in 4 replicas in each experiment. Error bars represent ± S.E.M.
Treatment Neurons ± SE Glia ±SE
Neuron/Glia
ratio
Control 440 9^ 912 14.6 0.48
5 jiM H2O2 129 132) 404 33.6 0 J2
10 jiM H2O2 15 1 88 5.1 0.17
25 jiM H2O2 1 0.3 15 2.6 0.06
Table 3.1 The effect o f increasing concentrations of H9 O2  on enteric neurons and glial cells in vitro.
Cell cultures were exposed to H2 O2 , fixed in 4% paraformaldehyde and subsequently stained with an antiserum to 
PGP 9.5. Cells were counted in a strip across the diameter o f  the coverslip, under X400 magnification using a 
Zeiss Axiophot microscope. Data in the table represents mean o f cell numbers collected in 3 separate 
experiments, with at least 3 replicas for each condition per experiment.
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However, neurons seemed to be more vulnerable to oxidative damage than glia, as indicated 
by greater rate of decline of neuronal numbers compared to glia with increasing concentrations 
of H2O2 . This trend is also indicated by analysis of neuronal to glial cell ratio, showing the 
shift towards the glial component with increasing concentrations of H2O2 .
3.5.2 Effects of NT-3 and GDNF on the viability of enteric ganglion cells exposed 
to oxidative stress.
To answer the question of whether NT-3 and GDNF can protect enteric ganglion cells from 
the deleterious effects of oxidative stress, cell cultures were supplemented with lOng/ml of 
NT-3 and GDNF 12 hours prior to exposure to H2O2 . This time point was chosen to reduce the 
effects of the known trophic actions of these factors on the cultures [153]. Once again, the 
MTS cell viability assay was used as a mean of measuring cell viability. Figure 3.2 illustrates 
the effect of incubating cell cultures with NT-3 for 12 hours before exposure to H2O2 .
NT-3 treated cultures displayed an increase in cell viability at every tested concentration of 
hydrogen peroxide, suggesting that NT-3 may be able to able to partially 
protect enteric ganglion cells exposed to oxidative stress. Statistical analysis of the data 
shows that although the difference between NT-3 treated cells and controls is consistent, it is 
only bordering on significance (p<0.1). Similar experiments performed using GDNF
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Figure 3.2 Viability o f cells treated with NT-3 (lOng/ml) prior to H2 O? exposure, compared with untreated 
controls. Values represent mean absorbance for each treatment obtained from three separate experiments, 
expressed as a percentage o f untreated controls. Data are presented as a mean o f  3 separate experiments, each 
treatment in four replicas per experiment. Enor bars represent ± S.E.M.
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Figure 3.3 Viability o f cells treated with GDNF (lOng/ml) prior to H2 O2  exposure, compared with untreated 
controls. Values represent mean absorbance for each treatment obtained from three separate experiments, 
expressed as a percentage o f untreated control. Data are presented as a mean o f 3 separate experiments, each 
treatment in four replicas per experiment. Error bars represent ± S.E.M.
showed no change in cell viability between controls and factor treated cells, indicating that 
GDNF is unable to rescue enteric ganglion cells exposed to oxidative stress (Fig. 3.3).
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3.5.3 Hoechst/Propidium Iodide staining of cell cultures exposed to H2O2 
combined with NT-3 and GDNF treatment
To complement the results obtained in the previous experiments, cells incubated with NT-3, 
GDNF or both, and subsequently exposed to oxidative stress were fixed and stained with bis- 
benzimide and propidium iodide (also known as live/dead stain) after 4 hours incubation with 
H2O2 . Both dyes stain cell nuclei, binding to the nucleic acids. While bis-benzimide is retained 
in the cells regardless of their status, propidium iodide is excluded from living cells, thus 
providing a way of measuring both total cell numbers and the extent of cell death. In this set of 
experiments only a single concentration of H2O2 was chosen based on MTS assay data, which 
showed roughly 40% cells surviving at lOpM. NT-3 and GDNF were used as in previous 
experiments at lOng/ml. The effect of combined NT-3/GDNF treatment was also investigated 
using lOng/ml of each factor. Cells stained with bis-benzimide and propidium iodide (Fig. 3.4) 
were subsequently counted, and analysed using one way ANOVA at p<0.05.
As expected, total (stained with Hoechst dye) cell numbers decreased in the control cultures 
exposed to H2O2 induced oxidative stress, compared with the untreated cultures (p<0.02.
Table. 3.2).
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GDNF NT-3 Control
Fig. 3.4 Hoechst (blue) and propidium iodide (red) staining o f cultures exposed to H2 O2  and controls, grown 
with NT-3 or GDNF (lOng/ml). Cultures were stained as described in materials and methods (see chapter 2, 
section 2.4.2). White arrows show strongly stained cells, indicative o f cell death as opposed to background 
staining o f live cells (green arrows). Pictures were taken at X400 magnification using a Zeiss Axiophot 
microscope. White bar at top right represents 50pm
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Treatment
HHzOz
Hoechst PI*
(+)H202
Hoechst PI*
Control 453 155 425 184
NT-3 434 144 431 141
GDNF 509 158 427 161
NT-3/GDNF 456 155 405 168
Table 3.2 Total cell numbers counted in the cultures grown for 12 hours with NT-3, GDNF or both (eaeh factor 
at lOng/ml concentration), treated and untreated with H2 O2 . Cells were counted in 5 random fields o f view across 
the coverslip under X 400 magnification, using a Zeiss Axiophot microseope. Data represent the mean o f  the cell 
numbers gathered in three separate experiments. * Propidium iodide
o 100
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Figure 3.5. The e fleet o f NT-3, GDNF and combined factor treatment on total (stained with bis-benzimide) cell 
numbers in the eultures of enteric ganglion cells. Factors (lOng/ml concentration) were added 12 hours prior to 
beginning o f the experiment. Data are presented as a mean o f  3 separate experiments. Error bars represent ± 
S.E.M. Asterisk marks statistically significant difference.
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GDNF increased total cell numbers present in the non-stressed cultures compared to controls 
(p<0.04, Fig 3.5), although this effect was abolished when the cultures were exposed to H2O2 . 
In agreement with the data obtained with MTS assay (Fig. 3.3), GDNF treatment was not able 
to rescue cells in F1202 treated cultures (Fig. 3.6)
In contrast to GDNF, NT-3 did not have any effect on total cell numbers, instead significantly 
decreasing the number of dead (stained with propidium iodide) cells in the cultures exposed to 
hydrogen peroxide compared with H2O2 treated controls (p<0.002. Fig. 3.6, Table 3.2). An 
interesting observation was that combined NT-3/GDNF treatment seemed to abrogate both the 
proliferative effect of GDNF as well as protective effect of NT-3 (Fig. 3.5 and 3.6)
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Figure 3. 6  The effect o f NT-3, GDNF and combined faetor treatment on cell survival. Presented values were 
calculated as a ratio o f total cell numbers to the number o f dead cells and expressed as a percentage o f  control. 
Factors (lOng/ml) were added 12 hours prior to H2 O9  treatment. All conditions received lOpM o f  tt2 0 2  and were 
stained with bis-benzimide and propidium iodide 4 hours after exposure to FI2 O2 , Data are presented as a mean o f  
3 separate experiments. Error bars represent ± S.E.M. Asterisk marks statistically significant difference.
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3.6 Discussion
The experiments described in this chapter were conducted in order to investigate whether NT- 
3 and GDNF can protect enteric ganglion cells exposed to oxidative stress. H2O2 was chosen 
to induce oxidative stress for several reasons, (i) H2O2 is one of the established models of 
inducing oxidative stress in vitro [Fuson et al. 1999, Mischel et al. 1997, Gotz et al. 1999].
(ii) Exogenous H2O2 can readily enter the cells due to its high membrane permeability 
[Sampath et al. 1994], and can induce apoptosis in many cell types [Clement et al. 1998]. (iii)
It is one of the naturally occurring oxygen radicals, arising as a product cellular metabolism, 
and it can give raise to many highly oxidizing radicals such as hydroxyl radical; it is also 
responsible for oxidative damage to the cells in vivo [Sastry et al. 2000]
It is well documented that both NT-3 and GDNF are able to rescue broad range of neuronal 
populations from various adverse conditions, including oxidative stress [Thrasivolou et al. 
2000, Mattson et al. 1997, Sawada et al. 2000].
NT-3, a member of the neurotrophin family, in addition to acting as a differentiation factor in 
the development of ENS and promoting development of neurons and glia from precursor cells 
[Semkova et al. 1999], also acts as a survival factor for various neuronal populations at certain 
stages of their development [Davies et al. 1994]. Similarly GDNF has been shown to be 
critical for the survival and proliferation of enteric precursor cells [Enomoto et al. 1998], as 
well as other classes of neurons. Both of these factors are present in the ENS throughout the 
life and have been shown to be necessary for survival of the enteric neurons during the 
development of ENS. Considering these facts, one might expect NT-3 and GDNF to serve as 
survival factors for enteric neurons facing adverse conditions, presuming such neurons express 
appropriate receptors, which has been shown for NT-3 [Stemini et al. 1995], it has been
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suggested that the same might be true for GDNF, which is confirmed by the responsiveness of 
neurons and glial cells used in current experiments to both NT-3 and GDNF stimulation.
The data presented in this chapter show that NT-3 may protect enteric ganglion cells from cell 
death induced by exposure to H2O2, as demonstrated by MTS cell viability assay and cell 
counts of cultures stained with propidium iodide and Hoechst dyes. The protective activity of 
NT-3 observed using the MTS assay was not dramatic. However, it was consistently observed 
at every tested concentration of H2O2 . The protective effects of NT-3 were much more 
pronounced when examined by cell counts of Hoechst/propidium iodide stained cells, showing 
an almost 24% reduction in the numbers of dead cells after exposure to H2O2 , compared to 
control cultures. The difference in strength of protective effect of NT-3 observed using MTS 
assay and Hoechst/propidium iodide staining could be explained in two ways. First, MTS 
assay offers only general information about the status of the cells in cultures, while 
Hoechst/propidium iodide staining in conjunction with cell counts offers much more accurate 
information, which allows detection of fine changes in cell death/survival. Another possible 
reason for the difference in the extent of protective effect of NT-3 is the different times of 
H2O2 exposure used for MTS assay and Hoechst/propidium iodide staining. After addition of 
H2O2, cell cultures were incubated for 6 hours before commencing MTS assay; to 4 hour 
incubation used for Hoechst/propidium iodide staining. Although H2O2 undergoes rapid 
decomposition in the culture medium even at highest, 25 pM concentration used in the 
experiments, vanishing in about 30 minutes, cell death induced by oxidative stress continues, 
which might contribute to the differences in the protective effect of NT-3 observed using MTS 
assay and Hoechst/propidium iodide staining.
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Protective effect of NT-3 on enteric neurons observed in this work remain in keeping with the 
reports of Thrasivolou et. al and Mattson et. al. [Thrasivolou et al. 2000, Mattson et al. 1995], 
showing protective effects of the neurotrophins against free radical damage as well as decrease 
in generation of free radicals. In contrast, Kirschner et.al. reported a lack of protective effects 
of NT-3 on stratial neurons of neonatal rats after MPP treatment, which blocks mitochondrial 
respiratory chain [Kirschner et al. 1996]. This discrepancy might be explained in several ways. 
First of all, models used for assessing protective effect of trophic factors differ in both studies. 
Secondly, the type of neurons employed (neonatal stratial neurons versus postnatal enteric 
neurons) might also contribute to the observed differences. Another explanation may be that 
different factors were used to induce neuronal death in these studies. Here, we have used 
hydrogen peroxide, while 1-methyl-4-phenylpiridinium (MPP), an inhibitor of mitochondrial 
complex 1 was employed in the other study. While both induce oxidative damage; hydrogen 
peroxide directly, and MPP by blocking the mitochondrial respiratory chain, the type of 
stimuli the cell receives in each case is likely to be different, possibly contributing to the 
different end effects.
The data gathered in this study indicate that GDNF does not protect enteric ganglion cells 
from oxidative stress, instead increasing cell numbers as shown by counts of bis-benzimide 
stained cells. On the other hand, Sawada et. al. demonstrated that GDNF was able to rescue 
mesencephalic neurons in vitro from chemically induced oxidative stress, as well as inhibiting 
apoptosis [Sawada et al. 2000]. Once again, the different effects of GDNF observed by 
Sawada et. al. and in this study could stem from several reasons, for example different cell 
types and cell age, as well as the different way of inducing oxidative stress: hydrogen peroxide 
versus glutamate and bleomycin sulphate. Also the intracellular signalling pathways avaible
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for GDNF in embryonic mesencephalic neurons and postnatal enteric neurons could be 
different, contributing to the different end effects observed.
One novel observation made in the present study is that combined NT-3/GDNF treatment 
seemed to abolish the effects of both factors, as measured by cell counts of bis-benzimide and 
propidium iodide stained cells. One possible explanation of this observation is the type of 
effect NT-3 and GDNF have on enteric ganglia. NT-3 enhances cell survival, and is also 
known to induce differentiation of the enteric neurons [Saffrey et al. 2000]. On the other hand 
GDNF induced an increase in cell numbers, possibly by promoting proliferation of the cells 
present in the cultures, which indicates that at the time of experiments enteric ganglion cells 
contain either precursor cells, or cells committed to particular phenotype but still able to 
proliferate. These two types of effects: growth and differentiation are mutually exclusive, 
hence cells that received both signals at the same time might not show any, or a decreased 
reaction depending on the environmental and intracellular conditions.
In conclusion, the results of this chapter demonstrate that NT-3 is able to rescue enteric 
ganglion cells exposed to oxidative stress in vitro, while GDNF does not affect cell survival, 
instead increasing total cell numbers present in the cultures. Also, combined factors treatment 
with both nullified the effects of each factors alone. The possible mechanisms by which NT-3 
and GDNF exert their effects on cultured enteric neurons are investigated in the subsequent 
chapters.
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Chapter 4
Effects of neurotrophic factors on the expression 
of antioxidant enzymes in the ENS
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Summary
The experiments described in this chapter were undertaken to examine the effects of two 
neurotrophic factors, NT-3 and GDNF on the expression of antioxidant enzymes in cultures of 
enteric ganglion cells in vitro. Western blot analysis was used to assess the levels of catalase 
and superoxide dismutase Cu/Zn (SOD Cu/Zn) present in enteric ganglion cells after 12 and 
36 hours incubation with NT-3 or GDNF. The results showed no change in levels of either 
enzyme at 12 hours in cultures incubated with NT-3, and a slight increase of SOD Cu/Zn 
levels in cultures treated with GDNF as compared to control cultures grown with no factors.
At 36 hours, the levels of catalase in cultures grown with NT-3 were comparable with 
controls, while levels of SOD Cu/Zn decreased. In contrast, cells that received GDNF for 36 
hours showed increased levels of both catalase and superoxide dismutase. The data suggest 
that these effects were caused by an increase in the levels of these enzymes present in the cells 
resulting from prolonged GDNF treatment. This observation implies that although NT-3 does 
not affect the levels of catalase of SOD Cu/Zn in cultures of enteric ganglion cells, GDNF is 
able to do so.
4.1 Introduction
As discussed in previous chapters, neurotrophic factors increase the resistance of multiple 
neuronal populations to adverse conditions, both during the development of neural networks 
as well as during adulthood. One particular type of insult causing cellular damage and decline 
of neuronal numbers during aging and pathological conditions in both the CNS and PNS is 
oxidative stress. There is evidence showing that neurotrophins can protect against oxidative
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stress by increasing the expression of the enzymes responsible for conversion of free radicals 
into less harmful compounds, both at the RNA and protein level [Sampath et al. 1994]. Such 
an effect, based on an increase in the levels of antioxidant enzymes has been suggested to be 
the mechanism by which NGF can protect cultured hippocampal neurons against direct 
oxidative damage [Cheng et al. 1991]. A similar protective effect has also been observed in 
vivo, when NGF administered intraventricularly protected hippocampal neurons against 
ischemic damage in rats [Shigeno et al. 1991]. Another member of the neurotrophin family, 
BDNF, has been shown to protect dopaminergic neurons in vivo against MPTP, which 
increases intracellular concentration of free radicals [Spina et al. 1992]. There are data 
showing that not only NGF and BDNF, but also growth factors from other families can protect 
various neuronal populations from oxidative stress, by means of increasing antioxidant 
defences of the cells. For example it has been demonstrated that GDNF is able to protect 
dopaminergic neurons in vivo from MPP^ toxicity by increasing activities of antioxidant 
enzymes [Chao et al. 1999].
The ability of neurotrophic factors to induce increases in the levels of antioxidant enzymes is 
of particular interest from a clinical point of view, as it could offer a way to counteract 
deleterious effects of many pathological conditions which elevate cellular levels of free 
radicals [Coyle et al. 1993]. It has also been shown that many age-related changes affecting 
neurons, such as lowered ATP production, increased leakage of free radicals from 
mitochondria and changes in antioxidant enzymes, are directly or indirectly related to the 
oxidative stress neurons are exposed to during their life [Artur et al. 1992]. In this context, 
increased resistance to oxidative stress offered by neurotrophic factors could be employed to 
counteract decreases in neuronal populations of both the CNS and ENS, which is likely to be, 
among other things, a cause of malfunction of gastrointestinal tract often seen in elderly.
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To date, caloric restriction is the only practical way of slowing down the onset of age-related 
changes, such as oxidative damage. Caloric restriction affects expression of a wide range of 
genes, many of which encode enzymes participating in energy metabolism [Dhahbi et al.
1999] which promotes more efficient energy usage, as well as enzymes involved in the 
metabolism of free radicals [Dhahbi et al. 1998]. It is possible that some of these effects are 
due to the actions of neurotrophic factors, since it has been demonstrated that caloric 
restriction is able to increase the levels of BDNF and other neurotrophic factors [Duan et al. 
2001].
4.1.1 Antioxidant enzymes in the nervous system
To cope with oxidative stress, eukaryotic cells utilize several antioxidative defence systems 
that prevent accumulation of ROS. One such system is that of the antioxidant enzymes, which 
catalyses conversion of ROS to non-toxic products: superoxide dismutase (SOD), catalase, 
glutathione peroxidase (GPx) and glutathione reductase (GR) (Fig. 4.1).
Superoxide dismutases rapidly convert superoxide anion (O2*') to hydrogen peroxide (H2O2). 
If not neutralized, H2O2 can undergo conversion to the more harmful hydroxy radical (HO ) in
the presence of transition metals such as iron and copper. Catalase and glutathione peroxidase 
decompose H2O2 to water.
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in eukaryotes, it differs from the intracellular Cu/Zn SOD in terms of amino acid composition 
and molecular weight [Marklund et al. 1984]. In most mammals extracellular SOD is a 
tetrameric molecule with a high affinity for heparin. Most of the extracellular SOD, that is 
about 90% of total enzyme present in the organism, is localized in the extracellular matrix of 
tissues [Oury et al. 1997]. Localisation of extracellular SOD is regulated by the presence of a 
heparin-binding domain in the carboxyterminal region of the protein [Sandstrom et al. 1992].
Catalases are divided into three subgroups: monofunctional haem catalases (typical catalases), 
catalase-peroxidases and manganese catalases. Members of haem catalases have been found in 
almost all aerobically respiring organisms, both prokaryotes and eukaryotes and genes coding 
for typical catalases have been isolated and sequenced from more than 75 organisms. Most of 
these catalases are homotetramers, between 200-340 kDa in size with four prosthetic haem D 
groups. The majority of catalases contain ferric protoporphyrin IX, but in some representatives 
haem d is employed. The conserved core of typical catalases comprises about 390 amino 
acids, spanning four structural domains. The highest degree of homology has been found in 
the area around the amino acids required for binding haem, this region is highly conserved in 
all currently resolved structures of typical catalases [Zamocky et al. 1999]. Members of the 
catalase-peroxidase subgroup in eukaryotes have been found only in fimgi. Their molecular 
weight varies from 120 to 340kDa and in general they are homodimers, although heterodimers 
have also been reported. The most characteristic feature of catalase-peroxidases is their 
bifunctional catalytic behaviour [Zamocky et al. 1999]. Manganese catalases are the smallest 
group of catalases, found in acid bacteria and thermophilic organisms. These enzymes are 
sometimes referred to as pseudocatalases due to the fact that they utilize manganese ions in 
their active sites instead of ferric haem.
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The last group of enzymes involved in the removal of free radicals are glutathione peroxidase 
(GPx) and glutathione reductase (GR), utilizing glutathione to decompose H2O2 . Glutathione 
(GSH) is a tripeptide consisting of glutamate, cysteine and glycine. The cellular levels of GSH 
are controlled by multiple enzyme systems such as y-glutamyltranspeptidase, amino acid 
transporters, glutathione synthetase (GS), GPx and GR, but the rate limiting reaction in GSH 
synthesis is catalysed by y-glutamyl cysteinyl synthetase (y-GCS) [Wild et al. 2000]. This 
makes regulation of y-GCS expression and activity critical for GSH homeostasis [Griffith et 
al. 1999]. The GCS holoenzyme is a heterodimer consisting of a catalytic, heavy subunit and 
regulatory, light subunit.
Under oxidative stress, ROS are reduced by GSH, which then forms the oxidized disulphide, 
GSSG. In addition to its action as a chemical antioxidant GSH also acts in the enzymatic 
conversion of H2O2, as a cofactor in GPx mediated reduction of peroxides, also resulting in the 
formation of GSSG. The next step involves reduction of GSSG to GSH by GR at the expense 
of NADPH. When the reductive capacity of a cell is insufficient, it causes a decrease of the 
GSH/GSSG ratio which in turn activates redox sensitive transcriptional factors [Sen et al. 
1996]. To maintain the cellular redox balance, surplus GSSG is exported from the cells by 
ATP dependent transport proteins, which suggests that severe oxidative stress can deplete 
cellular GSH [Leier et al. 1996]. Glutathione peroxidases can be divided into two types: 
selenium dependent and independent. GPx play an important role in the defence against 
oxidative stress. Resistance to oxidants such as H2O2 and menadione has been increased as a 
result of overexpression of the glutathione peroxidase GPxl [Mirault et al. 1991]. Conversely 
a GPx (-V) mouse strain was found to be hypersensitive to the oxidant paraquat and cortical 
neurons from that strain have been demonstrated to be more susceptible to insult exerted by 
H2O2 [Haan et al. 1998].
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4.1.2 Patterns of expression of antioxidant enzymes during aging in the nervous 
system and other tissues
Aging affects the expression of a whole range of genes, from metabolic enzymes and signal 
transduction proteins to antioxidant enzymes. There is some discrepancy in the data 
concerning the effects of aging on antioxidant defence systems. Age-dependent decreases in 
activities of antioxidant enzymes have been observed in several studies [Schisler et al. 1987] 
while no changes in expression of the same enzymes were detected by other groups [Liqun et 
al. 1998]. Decreases in both the activities of superoxide dismutases and amount of their 
mRNA as well as a decrease in catalase activity have been observed during aging in the liver 
of F344 rats [Rao et al. 1990b]. In the same study age-dependent decreases in SOD Cu/Zn and 
catalase, but not in GPx were observed in the brain, whereas levels of GPx in the intestinal 
mucosa and kidneys decreased. Somewhat contradictory to these results Liqun et. al. [Liqun et 
al. 1998] found that the activities of SOD Cu/Zn and SOD Mn in the heart and kidneys of 
F344 rats, and GPx activity in the kidneys were decreased during aging, but the activities of 
both SODs, catalase and GPx in brain were not affected by age [Liqun et al. 1998]. Different 
results have been obtained using the C57B1 mouse strain, which shows an age-dependent 
decrease in the brain levels of SOD Cu/Zn, GR, and catalase [Mo et al. 1995]. Data gathered 
by different groups suggests that the effect of aging on a particular antioxidant enzyme is 
influenced by strain of the animals, gender, and also the organ [Rikans et al. 1991, Egaas et al. 
1995]. The effect of age on antioxidant status in the intestine varies from study to study. The 
activity of SOD Cu\Zn in the intestine of F344 rats aged 26 months was significantly lower 
than that of the intestine from F344 rats aged 6 and 16 months, however intestinal GPx levels 
and lipid peroxidation were unaffected by age [Xia et al. 1995]. On the other hand, in a 
different study the activity of SOD Cu/Zn and lipid peroxidation were markedly increased in
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the intestine of aged mice [Cristiano et al. 1995]. Results obtained by Jang et al. [Jang et al. 
2001], comparing effects of aging on activities of SOD Cu/Zn, GPx and lipid peroxidation in 
intestine of Wistar and F344 rats show no changes in respect to both aging and strain. 
However, levels of glutathione s-transferase were elevated in the intestine of aged animals 
[Jang et al. 2001].
To add to the complexity of the picture, some data suggest that aging might affect different 
parts of digestive tract and other tissues differently. Microarray analysis of gene expression 
patterns in the duodenum and colon of young versus old F344 rats shows increased expression 
of GS gene in the colon, but decreased expression in the duodenum [Lee et al. 2001b]. This 
change seems to be part of the general change in the metabolism rate in the colon versus 
duodenum of aged rats: while the metabolic rate of the duodenum decreases, the metabolic 
rate of colon is increased [Lee et al. 2001b]. Such results suggest that the end effect of age on 
the levels of antioxidant enzymes in the intestine is dependent on many factors, both 
environmental and specific to a given cellular background.
4.1.3 Effects of caloric restriction on the expression of antioxidant enzymes in the 
nervous system and other tissues
As discussed in the general introduction (see section 1.5), caloric restriction is the only 
practical means of slowing down the onset of deleterious changes associated with aging 
available to date. It has been demonstrated that rats and mice kept on a calorically restricted 
diet, exhibit an extended lifespan and also show relatively less oxidative damage at the organ 
and cellular level [Mote et al. 1991]. Part of the anti-aging effect of caloric restriction is
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thought to be due more efficient utilization of available calories [Masoro et al. 2000], resulting 
in production of smaller quantities of fi*ee radicals [Ramsey et al. 2000], possibly by 
decreasing the rate at which mitochondria ’leak’ free radicals [de Grey et al. 2001]. However, it 
is known that caloric restriction alters the expression of enzymes involved not only in 
metabolism [Dhahbi et al. 2001], but also genes encoding at least some neurotrophic factors 
[Dhahbi et al. 2001] which might contribute to the reduced oxidative damage observed in 
calorie restricted animals. There are some data regarding changes in the expression of 
antioxidant enzymes resulting from caloric restriction. However, the results from different 
groups show certain differences in the effects of caloric restriction on the expression of 
particular enzyme depending on the strain of animals used in the study. For example Mote et 
al. reported decreased expression of SOD Cu\Zn in the liver of C57B1 male mice, while 
Chipalkatti et al. found no changes in SOD Cu\Zn activity in the liver of swiss albino female 
mice [Mote et al. 1990, Chipalkatti et al. 1983]. Similar discrepancies are found in the data 
concerning catalase expression. Studies in male F344 rats showed an increase of catalase 
mRNA in diet-restricted animals correlating with retardation of the effects of age [Rao et al. 
1990]. On the other hand, Mura et al. reports no changes in the protein levels of catalase in the 
liver of calorically restricted mice [Mura et al. 1996]. Similar differences in the results 
obtained by different groups are also evident in case of GPx and SOD Mn. One possible 
explanation is that the inconsistent results may stem from genotype differences, since genetic 
differences in the effects of food restriction have been noted in mice [Harrison et al. 1986]. 
These differences, in addition to different strains and gender variability of animals used by 
different groups highlights the fact that effects of caloric restriction on the protein and RNA 
levels of antioxidant enzymes is quite complex, and most likely regulated by multiple factors.
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4.2 Aims
The data obtained in the previous chapter indicated that NT-3 may have a protective effect on 
enteric ganglion cells exposed to oxidative stress. One likely explanation of this observation is 
an increase in the levels of antioxidant enzymes present in cultures caused by NT-3 treatment, 
a hypothesis supported by data from other studies showing the ability of neurotrophic factors 
to protect cultured cells from oxidative stress by means of increasing activities and levels of 
antioxidant enzymes. In order to examine this hypothesis, possible changes in protein levels of 
SOD Cu/Zn and catalase after NT-3 and GDNF treatment were investigated by western 
blotting. The expression of these enzymes by neuronal and glial cells, as well as numbers of 
neurons and glia present in the cultures were examined using immunohistochemical staining 
of cells grown in the presence of neurotrophic factors.
4.3 Methods
The methods used in this chapter were described in chapter 2 (sections 2.4.2,2.4.3, 2.6.2 and 
2.7).
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4.4 Results
4.4.1 Preparations of standard curves for catalase and SOD Cu/Zn
Western blotting allowed clear detection of protein levels of both SOD Cu/Zn and catalase in 
the range from 50 to 800 ng, as shown in Fig. 4.2. Following western blotting standard curves 
were prepared using a densitometry software package (Scion Image). Comparing 
densitometric values obtained from the samples with the values of standard curve allowed 
estimation of catalase and SOD Cu/Zn protein levels present in the cultures.
4.4.2 The effects of 12 hours treatment with NT-3 or GDNF on the levels of expression 
of catalase and superoxide dismutase Cu/Zn by enteric ganglion cells in vitro
The experiments described in the previous chapter demonstrated that NT-3, but not GDNF can 
protect enteric ganglion cells against cell death after exposure to H2O2 .
The effect of NT-3 could have been due to an increase in the levels of expression of 
antioxidant enzymes induced by the factor. To test this hypothesis, possible changes in the 
levels of catalase and SOD Cu/Zn in response to neurotrophic factor treatment were assessed. 
Cell cultures grown as described in materials and methods (section 2.1) were lysed after 12 
hours incubation with NT-3 or GDNF; cell lysates were subsequently analysed by western 
blotting. Optical density (OD) values of samples from NT-3 treated cultures collected from 
several experiments showed no significant changes in the levels of catalase after 12 hours 
incubation with the factor compared to untreated controls and only an insignificant drop in 
superoxide dismutase Cu/Zn levels (Fig. 4.3, Table 4.1).
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Figure 4.2 Western blots showing standard curves tor SOD Cu/Zn (A) and catalase (B), and respective graphs 
obtained after densitometric measurement o f both membranes. Values shown above the protein bands on western 
blots represent amounts o f puritted protein loaded per lane in nanograms.
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Similarly, GDNF treatment had little effect on the OD values obtained from western blots 
stained with anti-catalase antibodies, although the decrease in the level of SOD Cu/Zn was 
more pronounced than in case of NT-3 treatment.
Catalase SOD Cu/Zn
12 hours 36 hours 12 hours 36 hours
NT-3 98.5 (+4.4) 96.6 (+8.2) 98.7 (+3.2) 93.3 (+2.4)
GDNF 93.6 (+9.3) 123.4 (±11.6) 91.9 (+5.7) 132 (+11.9)
Table 4.1 The effects o f  factor treatment on the levels o f catalase and SOD Cu/Zn in the cultures grown for 12 
and 36 hours. Values represent the results o f densitometric analysis o f western blot membranes loaded with equal 
amounts of protein and expressed as a percentage o f respective controls. OD readings were standarized against 
the values obtained for total protein (ponceau red) staining o f  the respective membranes. Data presented in the 
table were gathered hom at least 5 separate experiments. Values in parentheses represent ± SEM.
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Figure 4.3 Example o f western blots o f lysates from sister cultures grown in the presence o f NT-3 or GDNF for 
12 hours prior to protein extraction, using antibodies directed against catalase (middle row) or superoxide 
dismutase Cu/Zn (bottom row). 5pg o f  protein extracts was loaded on to each gel. To ensure equal protein 
content on each lane after, electro blotting membranes were incubated with ponceau red (top row), and protein 
amounts were estimated using densitometry.
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Results obtained using western blots showed little change in the levels of catalase or SOD 
Cu/Zn after factor treatment for 12 hours. However, the presence of both neurons and glial 
cells in the cultures raised the question of the relative contribution of the two cell types to the 
total amount of catalase and SOD Cu/Zn protein detected using western blots.
To address this issue, membranes were stained using the general neuronal marker PGP 9.5, 
which gives an estimate of neuronal proteins present in the lysates. Such staining would allow 
an estimation of the contribution of neuronal cells to the levels of enzymes detected on 
western blots, by comparing the amount of neuronal protein present on the membrane with the 
amount of catalase and SOD Cu/Zn. However, the results of preliminary experiments were not 
conclusive. To overcome this problem a more direct approach was undertaken: cell cultures 
were grown for 12 hours with NT-3 and GDNF, fixed and stained using antibodies against 
catalase and SOD Cu/Zn and subsequently viewed using a Zeiss Axiophot microscope. Fig.
4.4 shows the results of staining of the cell cultures using antibodies directed against catalase 
and superoxide dismutase. Levels of both enzymes appeared to be slightly higher in neuronal 
cells than in glia (white arrows point to neurons, black arrow marks glial cell). As expected, 
no differences in the staining intensity of the cells were observed between treatments, 
supporting the results obtained by western blots.
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Figure 4.4 Immunohistochemical staining o f cultures o f enteric ganglion cells grown for 12 hours with NT-3 or 
GDNF. Each row shows the same field o f view, pictures taken in phase contrast in the left row (yellow), middle 
row shows catalase immunoreactivity visualised by fluorescein (green), right row shows SOD Cu/Zn 
immunoreactivity visualised by rhodamine red (red). White arrows show neurons (brightly stained by both anti 
catalase and anti SOD Cu/Zn antibodies). The black arrow marks a glial cell. Notice the group o f neurons present 
in the GDNF treated culture (marked with a white arrow). Pictures taken at X400 magnification using the same 
exposure time. White bar at the top left panel represents 50 pm.
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4.4.3 The effects of 36 hours treatment with NT-3 or GDNF on the levels of expression 
of catalase and superoxide dismutase Cu/Zn by enteric ganglion cells in vitro
To examine the longer term effects NT-3 and GDNF might have on the levels of catalase and 
SOD Cu/Zn, cultures of enteric ganglion cells were grown in the presence of either NT-3 or 
GDNF for 36 hours and subsequently used for protein extraction.
Western blot analysis revealed a slight decrease in the levels of SOD Cu/Zn in the cultures 
treated with NT-3 compared to the untreated control cultures; levels of catalase were not 
significantly affected (Fig. 4.5).
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Figure 4.5 Example o f western blots o f lysates from sister cultures grown in the presence o f NT-3 or GDNF for 
36 hours prior to protein extraction, using antibodies directed against catalase (middle row) or SOD Cu/Zn 
(bottom row). NT-3 treatment does not change catalase levels in the cultures, instead causing a drop in the levels 
o f superoxide dismutase, compared to untreated control cultures. GDNF treatment increased the levels o f  both 
enzymes tested after 36 hours incubation, especially SOD Cu/Zn. 5pg o f protein extracts was loaded on to each 
gel. To ensure equal protein content on each lane, after electro blotting membranes were incubated with ponceau 
red (top row), and protein amounts were estimated using densitometry.
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In contrast, cell cultures grown with GDNF showed an increase in the levels of both enzymes, 
especially that of superoxide dismutase (table 4.1). These results were confirmed by 
subsequent densitometric analysis of the membranes. An increase in the protein levels could 
stem from either an increase in the levels of catalase and SOD in the cells, or possibly a 
change in the proportion of neurons present in the cultures. To address this issue cell cultures 
grown for 36 hours with NT-3 and GDNF were stained using antibodies against catalase and 
SOD Cu/Zn and subsequently visualised using the Zeiss Axiophot microscope. As shown in 
Fig. 4.6, the relative intensity of catalase and SOD Cu/Zn staining does not appear to be 
different to the one observed in the cultures stained after 12 hours incubation with factors, 
which would argue against the upregulation of the levels of either catalase or superoxide 
dismutase.
On the other hand GDNF increased the relative number of the neurons present in the cultures 
as measured by cell counts of PGP 9.5 stained cultures fixed after 12 and 36 hours, especially 
in comparison to control cultures (Fig. 4.6, Table 4.2). Such an effect of GDNF could be due 
to induction of proliferation of precursor cells present in the cultures, or promotion of the 
survival of existing neurons, or both. This observation might suggest that the increase in the 
levels of catalase and superoxide dismutase detected by western blotting is caused by 
increased neuronal numbers present in the GDNF treated cultures compared to controls. 
However, data presented in Table 4.2 shows that the ratio of neurons to glial cells, and so their 
relative contribution to the total levels of both antioxidant enzymes detected by western 
blotting remains similar in the GDNF treated cultures both at 12 and 36 hours. This fact, in 
conjunction with western blots seems to indicate that GDNF is indeed able to upregulate the 
levels of both catalase and superoxide dismutase in the cultures of enteric ganglion cells.
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Figure 4.6 Immunohistochemical staining of cultures o f enteric ganglion cells grown for 36 hours with NT-3 or 
GDNF. Each row shows the same field o f view, pictures taken in phase contrast in the left row (yellow), middle 
row shows catalase immunoreactivity visualised by fluorescein (green), right row shows SOD Cu/Zn 
immunoreactivity visualised by rhodamine red (red). The staining intensity of catalase and SOD is comparable 
with cultures stained after 12 hours incubation with NT-3 and GDNF. Notice the group o f neurons present in the 
GDNF treated culture (marked with a white arrow). Pictures taken at X400 magnification using the same 
exposure time. White bar at the top left panel represents 50 pm.
Control NT-3 GDNF
neurons/glia 
neurons ratio
neurons/glia 
neurons ratio
neurons/glia 
neurons ratio
12 hours 159 (±0.36) 0.31 169 (±0.41) 0.36 176 (±0.55) 0.37
36 hours 119 (±0.32) 0.23 151 (±0.37) 0.29 195 (±0.44) 0.34
Table 4.2 Effect o f factor treatment on the mean number o f neurons, and the neuron to glial cells ratio in 
cultures o f enteric ganglion cells after 12 and 36 hour incubation. Cultures established as described in materials 
and methods were grown in the presence o f NT-3 or GDNF, both at lOng/ml concentration, fixed after 12 or 36 
hours and subsequently stained with PGP 9.5. Values represent the mean o f neuronal numbers counted in 3 
separate experiments, each treatment consisting of 3 replicas per experiment.
Values in parentheses represent ± SEM.
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4.5 Discussion
There are data supporting the view that neurotrophic factors can affect the levels and activities 
of the enzymatic antioxidant defences both in vivo and in vitro [Chao et al. 1999, Guegan et al. 
1999, Gabaizadeh et al. 1997]. This study concentrated on two of the antioxidant enzymes, 
SOD Cu/Zn and catalase, and tested changes in the protein levels of these enzymes in response 
to incubation of enteric ganglion cells with NT-3 and GDNF. Both SOD Cu/Zn and catalase 
participate in the metabolism of free radicals in cells. Cytosolic SOD Cu/Zn is a main enzyme 
utilized by cells to remove superoxide anions (O2* ) arising as a by-product of electron 
transport chain. It is known that damage to mitochondria could result in malfunction of 
electron transport chain which in turn could cause an increased leakage of O2* from 
mitochondria into the cell, therefore SOD Cu/Zn, as an enzyme participating in the removal of 
free radicals can contribute to increased survival of cells exposed to adverse conditions that 
impair mitochondrial function, such as oxidative stress.
In the model of oxidative stress used in this study, H2O2 was employed to induce oxidative 
stress. Since SODs are not able to use H2O2 as their substrate, the role of these enzymes in 
rescuing enteric ganglion cells subjected to H2O2 in vitro is probably limited to the removal of 
free radicals, such as superoxide anions arising in the cells as an effect of H2O2 interacting 
with cellular components. In the in vivo situation however, SODs are the first line of defence 
against superoxide radicals arising in mitochondria. Hence regulation of SOD activity and 
expression is important from a practical point of view, offering potential targets for therapies 
dealing with oxidative darriage to various tissues.
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On the other hand, catalase acts directly on H2O2. In an in vivo situation, H2O2 arising, among 
others, as a product of reaction catalysed by SODs is neutralized by catalase. In the 
experimental model used in this study, where H2O2 has been added directly into the culture 
medium, catalase would be one of the main enzymes responsible for dealing with deleterious 
effects of the oxidative stress.
The current set of experiments was designed to test the hypothesis that the neuroprotection 
offered by NT-3 observed in the previous chapter was due to an increase in the levels of 
antioxidant enzymes present in the cultured enteric ganglion cells.
The results of this study, however, showed that cultures of enteric ganglion cells grown for 12 
or 36 hours in the presence of NT-3 do not exhibit significant increases of the levels of either 
catalase or SOD Cu/Zn. This suggests that the neuroprotective effect of NT-3 on enteric 
ganglion cells exposed to oxidative stress is not due to the effect of NT-3 on the levels of these 
two enzymes.
It is known that NT-3 acts as a survival factor for neurons at certain stages of their 
development [Davies et al. 1994]. Considering that fact, as well as the known role of NT-3 in 
the maintenance and survival of some of neuronal populations during adulthood it stands to 
reason that NT-3 might have protective effects on ENS ganglion cells facing adverse 
conditions, assuming they express appropriate receptors, which is the case for enteric ganglion 
cells used in this study (Dolatshed, Safffey, personal communication). That, however, raises 
the question about the mechanism employed by NT-3 in protection of enteric ganglion cells 
exposed to oxidative stress. The hypothesis that NT-3 protects enteric ganglion cells exposed 
to oxidative stress by boosting their antioxidant defences is one of the possible explanations. If 
that is the case, then SOD Cu/Zn and catalase are two possible targets of NT-3: mitochondrial
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SOD Mn, GPx, GR or glutathione are remaining ones. Although the results obtained here 
argue against SOD Cu/Zn and catalase as mediators of NT-3 neuroprotection against oxidative 
stress, it has been shown that another member of neurotrophin family, NGF, can increase 
activity of glutathione peroxidase [Guegan et al. 1999], which suggests that protective effect 
of NT-3 might also rely, at least partially, on that enzyme. Other studies suggest that increased 
levels of SOD Mn conveys increased protection against free radicals. To address this 
possibility, attempts were made to examine the changes NT-3 and GDNF treatment might 
have on the levels of this enzyme. However, no conclusions could be drawn due to the low 
specificity of the several anti SOD Mn antibodies tested, which leaves open the possibility of 
induction of SOD Mn expression in response to NT-3 treatment.
Except for its effects on the level of expression of antioxidant enzymes tested in this study, it 
is also possible that protective actions of NT-3 treatment could have been due to increased 
activity of catalase or SOD Cu/Zn. If that is the case, then such action of NT-3 might explain 
the increased neuronal survival in the cultures exposed to H2O2 and grown with NT-3, as 
described in chapter 3. However, more data are required to confirm or reject this hypothesis.
The second neurotrophic factor tested, GDNF, had a marked impact on protein levels of 
catalase and SOD Cu/Zn, although the effect was most pronounced at the later, 36 hour time 
point. This result might seem contradictory to the lack of protective effect observed in the 
experiments described in the previous chapter. Immunohistochemical staining of cultures 
grown for 12 and 36 hours with GDNF, as well as data on cell numbers offer an explanation 
for this observation. Since the effects of GDNF treatment on the levels of catalase and SOD 
Cu/Zn, as well as on cell numbers became most prominent after 36 hours exposure, it is 
possible that the factor treatment had not exerted its full effects in the experiments discussed
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in chapter 3, where cultures were grown for just 12 hours with GDNF. Based on these results 
it seem safe to assume that the protective effects of GDNF treatment would be much more 
pronounced in the cultures exposed to H2O2 after GDNF treatment lasting 36 hours.
GDNF has been shown to be critical for the survival and proliferation of enteric precursor 
cells [Schafer et al. 1999], a similar effect of GDNF was also observed in this study, where 
GDNF increased cell numbers in the cultures. Cell counts of both Hoechst/propidium iodide 
and PGP 9.5 stained cells show an increase in both the glial and neuronal cell numbers after 
GDNF treatment (Fig. 3.5, Table 3.2 ,Table 4.2). This effect seems to continue throughout the 
time of the experiment as indicated by gradual increase of both neuronal and glial cell 
numbers with increased incubation times. This observation suggests that there are precursor 
cells present in the cultures, able to respond to GDNF treatment; a hypothesis supported by 
experimental data (A. Silva, personal communication).
Although cell cultures treated with GDNF showed increased neuronal and glial cell numbers 
compared to control or NT-3 treated cells, the proportion of neurons to glial cells remained 
constant between cultures grown for 12 and 36 hours. This observation, in conjunction with 
increased levels of catalase and SOD Cu/Zn observed in the cultures grown with GDNF for 36 
hours implies that GDNF is able to increase the expression of both enzymes in the enteric 
ganglion cells in vitro, however more data are required to confirm this hypothesis.
Comparing the results of this chapter with the ones obtained in chapter 3, one has to bear in 
mind small differences in experimental design used in the two sets of experiments. While in 
chapter 3 the cultures were grown for 12 hours with appropriate factor prior to H2O2 exposure, 
experiments in this chapter have been focused primarily on the effects of NT-3 and GDNF of
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the levels of antioxidant enzymes in the cultured enteric ganglion cells in the absence of H2O2 . 
Although in both sets of experiments cultures were grown with factors for 12 hours, the H2O2 
exposure might have caused changes in the levels or activities of antioxidant enzymes, 
different from the changes introduced by factor treatment alone. Although it is known that 
prolonged H2O2 exposure can induce expression of antioxidant enzymes in some cell types 
[Lai et al. 1996], its effects on the cells in the experiments described in this chapter and 
chapter 3 should be minimal, due to the short exposure time and rapid rate of decomposition 
of H2O2 in culture.
In summary, results of western blots and immunohistochemical staining of the cultures 
suggests that the neuroprotective effect of NT-3 on the enteric ganglion cells exposed to 
oxidative stress are not due to NT-3 induced changes of SOD Cu/Zn or catalase protein levels 
present in the cultures. These results also imply that the increased protein levels of these 
enzymes present in the cells treated with GDNF for 36 hours may be due to the increased 
expression of catalase and SOD Cu/Zn in the cells present in these cultures, as demonstrated 
by cell count data and western blot analysis. Alternative mechanisms of NT-3 induced 
neuroprotection are investigated in chapter 5.
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Chapter 5
Signalling pathways activated by NT-3 exposure 
in enteric ganglion cells in vitro
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Summary
The experiments described in this chapter were undertaken in order to examine the 
signalling events initiated by NT-3 and GDNF treatment in enteric ganglion cells in vitro.
Cell cultures grown with NT-3 or GDNF were treated with the phosphoinositide-3 kinase (PI- 
3K) inhibitor, LY294002. Inhibition of PI-3K resulted in drastic decrease of both neuronal and 
glial cell numbers after 12 hours, regardless of factor treatment. This effect was even more 
pronounced after 36 hours. Moreover, inhibition of PI-3K nullified the effects of NT-3 and 
GDNF treatment. These results imply that PI-3K is involved in the survival of cultured enteric 
ganglion cells, as well as participating in signalling events initiated by both NT-3 and GDNF.
Western blots performed on the cultures treated with NT-3 showed constant high levels of 
phosphorylated Akt protein present in these cells, independent of factor treatment.
In contrast, levels of phosphorylated MAPK/ERK kinase (MEK) and extracellular regulated 
kinase (ERK) proteins increased in response to NT-3 stimulation. Total protein levels of bcl-2 
and c-fos proteins were not affected by NT-3 treatment.
Combined NT-3 and LY294002 treatment significantly decreased the amount of 
phosphorylated Akt protein in the cultures. Upon addition of NT-3, a minor increase in the 
amount of phosphorylated Akt occurred, although not reaching the levels observed in the 
uninhibited cultures. The increase lasted until 20 minutes after NT-3 stimulation, with 
subsequent decline. LY294002 treatment did not affect the phosphorylation of either MEK or 
ERK, however levels of phosphorylated forms of both proteins peaked 20 minutes after NT-3 
addition and declined afterwards, similar to Akt. In contrast to Akt, MEK and ERK, inhibition 
of PI-3K caused an increase of total protein levels of bcl-2 and c-fos proteins.
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5.1 Introduction
As discussed in the general introduction (chapter 1, section 1.4.2) neurotrophins regulate 
growth, development, survival and repair responses of the nervous system [Yamamori et al. 
1992, Cowen et al. 1998]. All these actions are initiated by binding of neurotrophins to their 
receptors, the Trk tyrosine kinase receptors and the p75 neurotrophin receptor [Bothwell et al. 
1995]. These receptors can either collaborate with each other, or inhibit each other's actions; 
such functional interplay of Trk and p75 generates signals affecting neuronal behaviour. 
Interestingly, while Trk receptors transmit positive signals, such as enhanced neuronal 
survival and growth, p75 can transduce both positive and negative signals [Chao et al. 1994].
Our understanding of the signalling pathways involved in regulation of neuronal behaviour has 
grown considerably over last couple of years, with every year bringing discovery of new 
signalling molecules. Although complex, some of the mechanisms responsible for neuronal 
survival as well as differentiation responses have been elucidated in a degree allowing us to 
identify and describe key molecules in a given pathway, as well as their interactions. Recent 
investigations have started to unveil the fact that Trk/p75 signalling is regulated by connecting 
a variety of intracellular signalling cascades which include proteins encoded by proto­
oncogenes and tumor suppressor genes. To date, several intracellular signalling proteins and 
signal transduction pathways used by Trk and p75 have been identified. The first molecule 
shown to be activated by neurotrophins was Ras, a small GTP-binding protein. Although Ras 
is responsible for most of the survival responses initiated by neurotrophins, it does not act 
directly to promote survival, instead translating and directing signals initiated by 
neurotrophins into different signalling pathways.
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Two major pathways that play a role in the neurotrophin mediated signalling are the 
PI-3K /Akt and MEK/MAPK pathways, involved among others in survival, neurite outgrowth 
and differentiation responses. Both signalling molecules, as well as the pathways, are 
described below.
5.1.1 Signalling cascades initiated by the activation of Trk receptors
As mentioned above, Trk receptors initiate signalling cascades which follow two major 
pathways, the Ras/PI-3K/Akt and the MEK/MAPK/ERKpathways, shown in figure 5.1. Both 
cascades are initiated by binding of neurotrophins to their respective receptors, which in turn 
stimulates receptor transphosphorylation that results in recruitment of a series of signalling 
proteins to docking sites on the receptor. These proteins include She, which activates Ras 
through adaptor proteins Grb-2 and SOS [Kaplan et al. 1997], among others. At the point of 
Ras the signalling pathway forks, leading to the activation of the MEK/MAPK or PI-3K/Akt 
pathways.
The PI-3K pathway is activated by Ras, in turn activated by a group of adapter molecules 
[Yamada et al. 1997]. PI-3K stimulates the activities of many signalling proteins, among those 
proteins modulating execution of cell death program. It has been shown that some anti- 
apoptotic proteins have been induced in chick sensory and sympathetic neurons in a manner 
dependent on PI-3K activity [Wiese et al. 1999].
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Figure 5.1 An outline of two major pathways responsible tor inducing survival responses in neuronal cells, 
activated by Trk receptors. Binding o f ligand to Trk stimulates its phosphorylation, with subsequent recruitment 
of several auxiliary proteins. Signalling pathways diverge at Ras protein, which, depending on additional 
signalling events could direct it into PI-3K pathway or MEK/ERK pathway. Both pathways are discussed in more 
detail in the text.
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One of major downstream effectors of PI-3K is the serine/threonine kinase Akt, activated by 
PI-3K in response to NGF stimulation [Andjelkovic et al. 1998]. Akt acts on several target 
molecules; interestingly many proteins acted on by Akt have pro-apoptotic properties, and are 
inactivated as a result of Akt stimulation [Datta et al. 1999], which is the main mechanism by 
which PI-3Kthe /Akt pathway conveys its survival effects. One of the first reported targets of 
pro-survival activity of Akt was pro-apoptotic protein Bad
Phosphorylation by Akt has been found to induce association of Bad with anti-apoptotic 
protein 14-3-3, and prevented Bad from forming a complex with anti-apoptotic Bel proteins, 
which would inactivate them [Datta et al. 1997]. Evidence for the importance of Akt induced 
inactivation of Bad comes from overexpression experiments in cerebellar neurons, where 
insulin-like growth factor 1 (IGF-1) or constitutively active Akt suppressed the apoptotic 
activity of wild type Bad, but not of Bad mutated at the site phosphorylated by Akt [Datta et 
al. 1997].
Another protein target of Akt in neurons is a transcription factor Forkhead 1 (FKHRL 1). 
Genetic studies in C. elegans indicated that the activity of a forkhead family member, DAF 16, 
which contains an Akt consensus phosphorylation site, was suppressed by Akt [Paradis et al.
1998]. It has also been shown that expression of FKHRL 1 mutated at Akt phosphorylation 
sites increased apoptosis of cerebellar neurons cultured in IGF-1 [Brunet et al. 1999].
Data available to date on actions of Akt indicate that it may suppress apoptosis directly by 
inhibiting the activities of pro-apoptotic proteins Forkhead or Bad, increasing levels of anti- 
apoptotic proteins such as Bcl-2 or by blocking the apoptotic pathway in neurons.
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All these results suggest that a signalling pathway consisting of Ras/PI-3K/Akt is the major 
regulator of neuronal survival.
Although Akt is an important downstream effector of PI-3K activity, it is most probably not 
the only target of PI-K induced survival signalling, since inhibition of PI-3K is often more 
effective than inhibition of Akt at suppressing survival responses [Grewal et al. 1999]. A 
second pathway used by the neurotrophins consists of the Ras/MEK/MAPK pathway. The 
cellular responses initiated by this pathway include synaptic plasticity, long-term potentiation, 
survival and others. The major survival effect of this pathway is most likely protection of 
neurons from death due to injury or toxicity, rather than fi-om trophic factor withdrawal.
For example, in cortical neurons constitutively active MEK protected, and inhibition of MEK 
blocked BDNF regulated neuroprotection from campotheein induced apoptosis [Hetman et al.
1999]. Similarly, MEK/MAPK protected sympathetic neurons against apoptosis due to 
cytosine arabinoside [Anderson et al. 1999] and cerebellar neurons from apoptosis caused by 
oxidative stress [Skapner et al. 1998].
The effects of the MEK/MAPK pathway are achieved by stimulating the activity or expression 
of anti-apoptotic proteins, including the transcription factor CREB (cAMP response element 
binding protein) and Bcl-2. CREB is a mediator of neuronal survival, as dominant-inhibitory 
forms of CREB induced apoptosis of virtually all sympathetic neurons grown with NGF 
[Riceio et al. 1999], and also some neurons grown in BDNF. The activation of CREB by 
survival factors is likely to be due to phosphorylation by multiple kinases, including the 
MAPK activated kinase Rsk [Bonni et al. 1999].
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NGF strongly increased Bel-2 levels in sympathetic neurons, which in turn protected these and 
other neurons from apoptotic cell death [Michaelidis et al. 1996]. Inhibition of MEK/MAPK 
activity in PC12 cells completely blocked the ability of NGF to increase Bcl-2 levels [Liu et 
al. 1999], suggesting that Bel-2 is a transcriptional target of the MEK/MAPK pathway. Since 
CREB activity is also required for Bel-2 expression and survival induced by NGF in 
sympathetic neurons, it suggests that all these proteins might form a survival pathway for 
sympathetic neurons leading from Ras, through MEK and MAPK to CREB and Bcl-2.
In spite of the differences between neurotrophins and the GDNF family of neurotrophic 
factors, both employ similar intracellular signalling mechanisms. It has been shown that 
GDNF-induced Ret signalling activates both PI-3K/Akt and MEK/MAPK pathways [Chen et 
al. 2001], employing adaptor and effector proteins that also participate in neurotrophin- 
indueed signalling events [Takahashi et al. 2001].
5.1,2 Overview of signalling molecules involved in Trk/p75 receptor signalling
5.1.2.1 Ras
The Ras family was first identified as products of viral genes responsible for tumor formation 
in mice and rats [Kristen et al. 1967]. Ras proteins function as molecular switches determined 
by whether they are bound to guanine diphosphate (GDP), which is ’off position or guanine 
triphosphate (GTP), the ’on’ position. Inactive, GDP-bound Ras proteins are activated by 
interaction with members of large and structurally diverse class of proteins termed guanine-
105
nucleotide exchange factors (GEF's), which catalyse the release of GDP, which is replaced by 
GTP [Lenzen et al. 1998].
One of the best characterized signal transduction pathways downstream of p21 Ras is the one 
that leads to activation of members of the mitogen-activated protein (MAP) kinase family, 
especially Erk 1/2, which requires binding of Ras to members of the Raf family of 
serine/threonine kinases [Vojtek et al. 1993, Zhang et al. 1993].
Another effector ofp21 Ras is phosphatidylinositol-3 kinase (PI-3K). Its catalytic subunit 
interacts directly with GTP-bound Ras [Rodriguez et al. 1994]. Some members of Ras family 
might increase activity of PI-3K more efficiently than others [Marte et al. 1997, Yan et al. 
1998].
5.1.2.2 PhosphatidyIinositol-3 kinase (PI-3K)
The PI-3 kinases are a family of enzymes that phosphorylate the hydroxyl group of 
phosphoinositides. Based on sequence homology and substrate preference, PI-3Ks have been 
divided into 3 classes, of which class I is mostly involved in transducing signals initiated by 
binding neurotrophins to Trk receptors.
Class I PI-3Ks regulate many cellular functions, including apoptosis, cellular proliferation, 
vesicular trafficking, eytoskeletal structure and cellular morphology, glucose utilization, 
protein biosynthesis and lipid metabolism. Enzymes of this class
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consist of heterodimeric enzymes composed of a catalytic subunit and an adaptor/regulatory 
subunit [Chan et al. 1999]. There are two major subclasses of the catalytic subunit, la and Ib. 
Both subclasses contain carboxy-terminal catalytic and phosphatidylinositol kinase domains 
and an amino-terminal Ras binding domain. There are also two main regulatory subunits, 
containing two carboxy-terminal Src homology-2 (SH2) domains, as well as amino-terminal 
proline binding SH3 domain.
The biological significance of the multiple catalytic and regulatory subunits is not completely 
understood. All the regulatory subunits can associate with and recruit all the catalytic subunits 
to proteins containing appropriate motifs which contain phosphorylated tyrosine. The 
functional overlap between these molecules is further supported by genetic studies in mice. 
Mice homozygous for the targeted disruption of the entire regulatory subunit gene die 
perinatally [Fruman et al. 1999], while knockout mice that express amino-truncated 
versions of this protein survive the perinatal period [Suzuki et al. 1999].
Some of the differences regarding the biological roles of these proteins could be caused by 
differences in their patterns of expression in different organs and cells. For example, while 
some catalytic subunit isoforms are widely expressed, expression of others is restricted to 
certain cell types [Vanhaesebroeck et al. 1997].
107
5.1.2.3 Akt
Akt, also known as protein kinase B (PKB) was originally identified as a viral oncogene.
At present, three members of the Akt family have been identified. Although they are products 
of different genes, they are highly related, showing more than 80% sequence homology 
[Nicholson et al. 2002]. The Akt family of kinases is evolutionarily conserved in all 
eukaryotes.
Inactive Akt localizes in cytosol; it is recruited into the plasma membrane by the lipid 
products of PI-3K in response to a variety of stimuli, including hormones, growth factors and 
cytokines. Subsequently Akt undergoes phosphorylation which results in its activation 
[Nicholson et al. 2002].
In neurons, Akt has only been shown to regulate survival, and not any other responses such as 
neurite outgrowth or differentiation. Thus all of the proposed direct targets of Akt identified so 
far have been proteins that regulate cell survival, such as Bad (inhibitor of anti apoptotic 
protein Bcl-2), pro-easpase 9 and forkhead, a transcription factor inducing apoptosis, among 
other things. In each ease Akt suppresses apoptosis by phosphorylating the apoptotic protein at 
the Akt consensus phosphorylation site.
Data gathered to date indicate that Akt plays a role in the survival of cerebellar neurons 
induced by IGF-1 treatment [Dudek et al. 1997] as well as survival of sympathetic neurons 
induced by NGF [Virdee et al. 1999]. Akt not only mediates growth factor regulated cell 
survival, but also neuronal survival promoted by depolarisation [Crowder et al. 1999].
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5.1.2.4 MAP kinases
The mitogen activated protein kinases (MAP kinases) comprise a family of related serine- 
threonine protein kinases that regulate signalling leading to a variety of cellular responses 
ranging from apoptosis and oncogenic transformation to inflammatory responses. Components 
of the MAP kinase pathways are evolutionarily highly conserved in structure and organisation, 
each consisting of a module of three cytoplasmic kinases: a mitogen-activated protein (MAP) 
kinase kinase kinase (MAPKKK, eg. RaQ, MAP kinase kinase (MAPKK, eg. MEK) and the 
MAP kinase, eg. ERK (Fig. 5.2). The first member of the pathway is MAPKKK, which is a 
serine-threonine kinase that receives activating signals from a transmembrane receptor and 
then phosphorylates and activates its substrate, MAPKK. MAP kinases have the potential to 
phosphorylate other cytoplasmic proteins, as well as translocate from cytoplasm to the 
nucleus, where they directly regulate the activity of transcription factors controlling gene 
expression.
The best understood MAPK signal transduction pathway of mammalian cells is the one 
formed by the RafrMEK/ERK kinases. Proliferative signals induced by growth factors cause 
activation and autophosphorylation of their cognate receptor tyrosine kinases. The 
phosphorylated tyrosine residues of the receptor serve as docking sites for the adaptor 
proteins, which activate Ras, which in turn recruits the MAPKKK protein Raf to the plasma 
membrane where it is activated. The precise mechanism of Raf activation is not clear, but 
activated Raf signals via MEK to ERK [Daum et al. 1994].
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Figure 5.2 Schematic representation o f MEK/ERK signalling pathway in mammalian cells. The activity o f  this 
pathway affects a range o f  different transcription factors (TF), either by repressing, or by stimulating their 
activity. For more details see text.
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Activation of MEK by Raf involves phosphorylation on two serine residues, which 
subsequently leads to phosphorylation of ERK by MEK. Such a mode of signalling amplifies 
the signal; there are some data suggesting that activation of only small number of Ras 
molecules is sufficient to induce full activation of ERK [Hallberg et al. 1994]. Activated ERK 
phosphorylates its substrates localized in practically all cellular compartments [Lewis et al.
1998].
There are two isoforms of ERK; ERKl and ERK2. Their specific roles are not yet fully 
understood. Both isoforms are widely expressed, and share large degree of homology in their 
amino acid sequence as well as similar substrate specificity. However, knockout of one of the 
isoforms produces different results. ERKl null mice are viable, fertile and of normal size 
[Pages et al. 1997].
In these animals ERK2 can compensate for most of the functions of ERKl, with the exception 
of thymocyte maturation which is impaired [Traverse et al. 1992]. On the other hand, ERK2 
knockout is lethal at early embryonic stages, about day 6.5 [Pouyssegur et al. 2002]. 
Considering the pleiotropie substrates and the ubiquitous expression of ERK, cell specific 
regulation must occur to ensure transduction of cell-specific signals. For example, expression 
of one of the ERK regulator proteins is restricted to only a few cell types, such as terminally 
differentiated astrocytes [Kahan et al. 1992].
In a single cell, activation of the ERK pathway can lead to antagonistic effects, for example in 
PCI2 cells both differentiation after NGF treatment and cell proliferation resulting from EGF 
stimulation require ERK activation. In PCI 2 cells EGF causes transient activation of ERK, 
while NGF promotes sustained activation of ERK, hence the duration of ERK activation
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specifies cellular response [Traverse et al. 1992]. It has also been shown that strong ERK 
activation protects cells from apoptosis induced by anchorage and serum removal, whereas 
moderate activation of ERK is necessary to permit apoptosis.
5.1.2.5 c-fos
c-Fos can be activated by many signalling cascades, among those the PI-3K/Akt and the 
MEK/ERK described above. The Fos (AP-1) family consists of the transcription factors, 
which form homodimers or heterodimers with each other and which bind to a specific DNA 
sequence called AP-1. Fos proteins are a nuclear proteins, with DNA-binding and gene 
activator properties [Sambueetti et al 1986]. They are also functionally related to c-Jun 
proteins [Rausher et al. 1998].
Because of the structural differences, c-fos cannot form homodimers the way c-jun does 
[Neuberg et al. 1989], and c-fos proteins cannot bind to DNA unless they dimerize with jun 
proteins [Chiu et al. 1988]. However, c-fos enhance DNA binding in these dimers due to the 
fact that some of the jun proteins are unable, or able to only weakly bind DNA.
The convergence of pathways on the e-fos promoter has been extensively studied in vitro and 
in vivo. The second messenger pathways include those activated by neurotransmitters and 
hormones, and the Ras- and mitogen stimulated pathways which are particularly effective in 
initiating c-fos expression [Karin et al. 1995, Morgan et al. 1991]. In neuronal PCI2 cells and 
other neuronal species in vitro, the expression of e-fos can be induced by many agents, for 
example neurotransmitters such as aeetylocholine or growth factors such as NGF and insulin
112
[Bartel et al. 1989, Curran et al. 1985]. In the case of growth factors, induction of c-fos occurs 
after ligand binding to membrane-bound tyrosine kinase receptors [Karin et al. 1994]. 
Inhibition of phosphorylation PI-3K in rat 3T3 cells blocks the insulin-induced synthesis of 
DNA and c-Fos by about 85% [Jhun et al. 1994].
Degradation of c-fos is governed by two instability domains within its transcript [Chen et al. 
1994]. Depending on these sequences the half-life of e-fos is about 15 minutes, but saturation 
of degradation machinery when there are high concentrations of c-fos extends this time to 100 
minutes. The c-fos/jun dimers binding to specific DNA sequences stimulate expression of a 
range of proteins. In neurons, these include, but are not restricted to neurotransmitter 
receptors, ion channels, eytoskeletal structures as well as proteins required for 
neurotransmitter synthesis [Herdegen et al. 1998]. Also there are data linking c-fos to 
developmental apoptosis [Smeyne et al. 1993].
5.1.2.6 bcl-2
Bcl-2 was initially shown to inhibit cell death induced by deprivation of interleukin 3, and 
subsequently shown to inhibit cell death induced by other stimuli including chemotherapeutic 
agents and heat shock [Tsujimoto et al. 2000]. In recent years, it has been established that 
Bel-2 prevents most forms of apoptotic cell death as well as some forms of necrotic cell death. 
A large number of Bcl-2 related proteins have been isolated and divided into 3 major groups 
[Adams etal. 1998].
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The first group is formed by anti-apoptotie members of the family, such as Bcl-2, which exert 
anti cell death activity. Proteins from this group also share a sequence homology, especially 
within four domains called Bcl-2 homology (BH) Ito 4, responsible for the dimerization, 
channel formation as well as other activities. The second group is formed by pro-apoptotic 
proteins such as Bax, which share sequence homology in BHl, 2 and 3, but not in BH4 
domain. Finally the last group comprises of proteins which have pro-apoptotic fimction, such 
as Bik and others, which share homology only within BH3 domain.
One of the unique features of the Bcl-2 family proteins is heterodimerization between anti 
apoptotic and pro-apoptotic proteins, which is thought to inhibit the biological activity of the 
proteins forming the heterodimer. Formation of heterodimer is accomplished by insertion of 
BH3 region of a pro-apoptotic protein into a hydrophobic pocket present on the anti-apoptotic 
protein [Sattler et al. 1997]. In addition to the regulation of apoptosis by heterodimerization of 
anti-apoptotic and pro-apoptotic proteins from the Bcl-2 family, some members of the Bel-2 
family have been suggested to regulate apoptosis independently of each other. These 
observations are consistent with the findings that some Bcl-2 proteins, such as Bcl-2, B c1 -x l 
and Bax can form channels in synthetic lipid membranes [Schendel et al. 1997, Sehlesinger et 
al. 1997]. Among other functions, proteins of the Bel-2 family also play a key role in 
controlling the activation of caspases: enzymes involved in the execution of cell death 
program [Korsmeyer et al. 1999], by controlling the release of cytochrome c which is one of 
the events required for initiation of apoptosis. Proapoptotie proteins, such as Bax and Bak 
increase mitochondrial permeability, allowing cytochrome e to pass into the cytoplasm, 
whereas antiapoptotic members: Bel-2 and B c1 -x l prevent release of cytochrome c. In 
addition, Bcl-2 is able to regulate activation of the caspase cascade independently of 
cytochrome e [Krebs et al. 1999]. Bcl-2, as well as the other proteins described above,
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participates in signalling events initiated by the neurotrophie factors binding to their receptors. 
Although there is a considerable amount of data on the intracellular mechanisms employed by 
neurotrophic factors in numerous cell types, available data regarding these events in the 
enteric neurons is sparse. The aim of this study was to investigate the signalling events 
initiated by neurotrophic factors in the enteric neurons and glial cells.
5.2 Aims
The experiments described in this chapter were performed to investigate the signalling 
pathways involved in the molecular mechanisms underlying the effects of NT-3 observed in 
previous chapters. Preliminary experiments were designed to examine the role of 
PI-3K in the survival of the cultured enteric ganglion cells grown with NT-3 and GDNF. PI- 
3K activity was blocked using LY294002 inhibitor in the cultures and cell numbers were 
counted afterwards. The second set of experiments focused on the short term effects of NT-3 
or NT-3 and LY294002 treatment on the level of the phosphorylated forms of several key 
signalling molecules including MEK, ERK and Akt, as well as total protein levels of c-fos and 
bcl-2. Western blots were performed on cell lysates obtained from NT-3 treated or factor and 
LY294002 treated cultures, using antibodies against phosphorylated forms of these proteins 
excluding c-fos and bel-2, where total protein levels were examined.
5.3 Methods
The methods used in this chapter were described in chapter 2 (sections 2.4.1, 2.5, 2.6.1 and 
2.7)
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5.4 Results
5.4.1 The effects of PI-3K inhibition on the survival of enteric ganglion cells grown 
for 12 and 36 hours.
The two main pathways activated by neurotrophie factors in neurons are the PI-3K/Akt and 
the MEK/ MAPK pathways, responsible for modulating cellular responses to trophic factor 
stimulation. Experiments described in previous chapters focused on the general responses of 
enteric neurons to NT-3 and GDNF. The aim of this study was to examine molecular 
mechanisms underlying the effects of NT-3 and GDNF.
A preliminary set of experiments was designed determine whether PI-3 K plays a role in the 
NT-3 and GDNF induced survival of enteric ganglion cells. To examine the role of PI-3K, 
cultures of enteric ganglion cells were established as described in materials and methods, and 
grown without factors or in the presence of NT-3 or GDNF with or without the specific 
inhibitor of PI-3K, LY294002 (300pM) for 12 and 36 hours. After these times the cultures 
were fixed, and neurons and glial cells were identified following staining with PGP 9.5. Cells 
were subsequently counted using a Zeiss microscope under 400X magnification.
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The effect o f PI-3K inhibition on cell numbers and cell morphology
In the cultures whieh did not receive factors, inhibition of PI-3K was observed to have a 
marked effect at the 12 hour time point, and its effects were much more prominent after 36 
hours. Both neuronal and glial cell numbers were decreased compared to controls 
(see figures 5.4 and 5.5).
A similar effect was observed in NT-3 and GDNF treated cultures; a typical morphological 
response observed in the cultures treated with NT-3 and GDNF, that is neurite outgrowth 
caused by NT-3 and formation of neuronal cell clusters initiated by GDNF were reduced as a 
result of PI-3 K inhibition (Fig. 5.3). After 36 hours incubation with LY294002, its effects 
were even more pronounced, with a drastic decrease of both neuronal and glial cell numbers, 
as well as the abolition of the morphological responses initiated by NT-3 and GDNF treatment 
(Fig. 5.4). In addition, some cells in the cultures treated with LY294002 showed signs of 
apoptotic cell death, that is condensation of chromatin and membrane blebbing at 12 hours 
time point; their number increased at 36 hours time point (not shown).
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Figure 5.3 PGP 9.5 staining o f cultured enteric ganglion cells grown for 12 hours without (left panel) or with 
LY294002 inhibitor (right panel). Control cells grown without inhibitor, as well cultures that received factor 
treatment display morphologies typically observed at this period. Note the group o f neuronal cells present in the 
GDNF treated culture, as well as processes grown by neurons after NT-3 treatment. In contrast, LY294002 
decreased cellular numbers in every treatment, as well as partially abolished the effects o f both neurotrophic 
factors, as shown by lack of neuronal processes in the NT-3/LY294002 treatment and decreased number of  
neuronal cell clusters in GDNF/LY294002 treatment. Pictures taken under 400X magnification, white bar at the 
top left picture represents 50pm.
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Figure 5.4 PGP 9.5 staining o f cultured enteric ganglion cells grown for 36 hours without (left panel) or with 
LY294002 inhibitor (right panel). Again, cells grown without inhibitor display typical morphologies observed at 
this time period. Cultures incubated with GDNF for 36 hours contain a large number o f  neuronal cells forming 
clusters, while NT-3 treatment promotes formation o f  long processes by neuronal cells. The effects o f  P1-3K 
inhibition are much more pronounced at 36 hours time point. Both neuronal and glial cell numbers were 
significantly decreased, and morphological responses initiated by factor treatment also were very limited. 
Pictures taken at 400X magnification, white bar at the top left panel represents 50pm.
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Analysis o f cell numbers
Cell counts of the cultures confirmed the visual observations as summarized in Table 5.1 and 
Figures 5.5, 5.6, 5.7 and 5.8.
12 hours
Control 
neurons glia
NT-3 
neurons glia
GDNF 
neurons glia
Control 159 ±0.69 501 ±0.36 189 ±0.67 462 ±0.41 176 ±0.52 468 ±0.33
LY294002 69 ±0.73 256 ±0.33 58 ±0.72 244 ±0.32 60 ±0.72 242 ±0.33
36 hours
Control 119 ±0.70 509 ±0.30 151 ±0.72 512 ±0.87 195 ±0.75 564 ±0.44
LY294002 30 ±0.55 87 ±0.31 25 ±0.37 89 ±0.34 40 ±0.70 101 ±0.43
Table 5.1 The effect o f  LY294002 inhibition on cultures o f enteric ganglion cells grown without factors and 
with NT-3 or GDNF for 12 and 36 hours. Both factors were used at lOng/ml. LY294002 was used at 300pM. 
Cultures grown for the designated times were fixed with 4% paraformaldehyde, stained against the pan neuronal 
marker PGP 9.5 and subsequently counted using a Zeiss microscope at X400 magnification, as described in 
chapter 2, section 2.5. Data presented are the average number o f  neurons and glial cells counted in 3 separate 
experiments, 4 replicas o f  each treatment per experiment. Values to the right o f  cell numbers represent ±SEM
Analysis of glial cell numbers present in the cultures after 12 hours incubation with LY294002 
showed a significant, approximately 50% decrease compared to respective uninhibited 
cultures (table 5.1, Fig. 5.5). The effects of PI-3K inhibition on glial cell numbers differed 
slightly between cultures grown with and without factors. However, the differences were not 
statistically significant.
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Figure 5.5 The effects o f PI-3K inhibition on mean glial cell numbers after 12 hours incubation. Data are 
presented as a mean o f  3 separate experiments, each treatment done in 4 replicas in each experiment. Error bars 
represent ± S.E.M.
Neuronal numbers in the cultures grown without factors decreased by 56% after 12 hours 
incubation with LY294002, compared to uninhibited counterparts. Both NT-3 and GDNF 
treated cells displayed an approximately 65% reduction of neuronal cell numbers, compared to 
respective uninhibited cultures (table 5.1, Fig. 5.6). The number of neurons surviving in each 
condition is not statistically different; the apparent bigger neuronal loss in factor treated 
cultures stems from the increased neuronal numbers in the uninhibited, factor treated cultures 
compared to cultures grown without factors or LY294002 (Table 5.1), which suggests that 
LY294002 treatment can nullify the beneficial effects of both NT-3 and GDNF (Fig. 5.6).
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Figure 5.6 The effects o f PI-3K inhibition on mean neuronal cell numbers after 12 hours incubation. Data are 
presented as a mean o f 3 separate experiments, each treatment done in 4 replicas in each experiment. Error bars 
represent ± S.E.M.
Changes between inhibited and uninhibited eultures were even more pronouneed at the 36 
hour time point. LY294002 treatment caused a 83% reduction of glial cell numbers 
irrespective of factor treatment (Fig. 5.7).
Similarly, neuronal cell numbers in the inhibited cultures declined further than at 12 hours 
time point. P1-3K inhibition in the eultures grown without factors resulted in 75% reduction of 
neuronal numbers compared to uninhibited eultures (Fig. 5.8). LY294002 treatment of the 
eultures grown with NT-3 caused 84% reduction of neuronal numbers; a similar effect was 
observed in the inhibited cultures grown with GDNF, whieh displayed 80% neuronal decline 
compared to respective uninhibited controls (Fig. 5.8).
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Figure 5.7 The effects o f PI-3K inhibition on mean glial cell numbers after 36 hours incubation. Data are 
presented as a mean o f 3 separate experiments, each treatment done in 4 replicas in each experiment. EiTor bars 
represent ± S.E.M.
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Figure 5.8 The effects o f PI-3K inhibition on mean neuronal cell numbers after 36 hours incubation.
Data are presented as a mean o f  3 separate experiments, each treatment done in 4 replicas in each experiment. 
Error bars represent ± S.E.M.
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The increased neuronal death rate observed in the inhibited cultures grown with NT-3 and 
GDNF compared to LY294002 treated cells grown without factors results from increased 
neuronal survival in factor treated, uninhibited cultures; the actual numbers of neurons 
surviving in LY294002 treated cultures at 36 hours are comparable in each condition tested. 
Such an effect was also observed in cultures grown for 12 hours (Table 5.1).
Comparison of the effects of PI-3K inhibition on neuronal and glial cell numbers between 
cultures grown for 12 and 36 hours reveals two facts. While glial cell numbers are affected to 
a lesser degree that neurons in cultures grown with inhibitor for 12 hours, continuous 
inhibition of PI-3K results in reduction of glial cell numbers comparable with that of neurons 
in cultures grown for 36 hours. Secondly, inhibition of PI-3K abolishes the beneficial effects 
of both NT-3 and GDNF on enteric neurons at both time points examined, reducing neuronal 
cell numbers in factor and inhibitor treated cultures to that of LY294002 treated control 
cultures.
5.4.2 Changes in the phosphorylation status of Akt, MAP and ERK kinases 
after NT-3 or combined NT-3/LY294002 treatment.
The results of the previous set of experiments have shown that PI-3K plays crucial role in the 
survival of enteric ganglion cells in vitro. The next set of experiments was performed in order 
to analyse the signalling pathways that are activated by neurotrophic factors in enteric 
ganglion cells in more detail.
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Of the two neurotrophic factors tested, NT-3 exhibited a potential to protect enteric ganglion 
cells by initiating survival responses in the cells, while the effect of GDNF was primarily to 
increase cell numbers in the culture, perhaps by promoting proliferation. Based on these 
observations, further experiments concentrated on investigating the signalling cascades 
initiated by NT-3. It is accepted that NT-3/Trk binding initiates signalling along two major 
pathways, that of PI-3K/Akt and Raf/MEK/MAPK. Based on this information, the 
phosphorylation status of key molecules in these pathways, Akt, MEK and ERK was 
examined.
Due to the rapid nature of signal transduction cascades, lysates from cell cultures exposed to 
NT-3 were collected at the end of short intervals (0, 5, 20, and 35 minutes) after treatment and 
processed for western blotting. To address the question of the effect of PI-3K inhibition on 
NT-3 initiated signalling, designated cultures were incubated with LY294002 inhibitor at 
300pM concentration for 30 minutes at 37°C, 2.5% CO2 before NT-3 treatment to allow 
complete inhibition of PI-3K. Figure 5.9 shows the results of representative western blot 
immunolabelled with antibodies against phosphorylated forms of Akt, MEK and ERK 
proteins. Results obtained in separate experiments were comparable with the ones presented in 
the figure.
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Figure 5.9 Western blotting against phosphoiylated Akt, MEK and ERK proteins. Cell cultures established as 
described in materials and methods were grown tor 12 hours, and subsequently exposed to lOng/ml NT-3. Cells 
were collected at 0, 5, 20, 35 and 55 minutes after NT-3 treatment and processed for western blotting. LY294002 
treatment was initiated 30 minutes before addition of NT-3 to allow inhibition o f PI-3K. 5pg o f protein extracts 
was loaded on to each gel. To ensure equal protein content on each lane, membranes after electro-blotting were 
incubated with ponceau red (top lane), and protein amounts were estimated using densitometiy.
Phosphorylation levels of Akt remained eonstant at every time point examined, suggesting that 
exposure to NT-3 does not have an effect on the phosphorylation status of Akt. Considering 
the well-established role of the PI-3K/Akt pathway in survival responses in a number of 
different neuronal populations, it stands to reason that the PI-3 K/Akt pathway is necessary for 
the survival of enteric ganglion cells in vitro, a conclusion supported by the data obtained in 
PI-3K inhibition experiments described in the previous section. In agreement with that 
hypothesis, LY294002 pretreatment reduced the amount of phosphorylated Akt. Although 
levels of phosphorylated Akt were lower in the LY294002 treated than in untreated cultures, 
densitometric analysis of the western blots of LY294002 treated cultures indicates a small 
increase of the levels of phosphorylated Akt following NT-3 treatment, reaching maximum 20 
minutes after factor treatment, with a subsequent decline in the signal strength (Table 5.2, Fig. 
5.10)
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O'
control 
5' 20' 35' O'
LY294002 
5' 20' 35'
Akt 142+12 133+7 146+12 144+6 72+8 103+8 195±16 93+6
MEK 0 198+11 224+12 154±16 96+11 231+19 308+21 130+18
ERK 0 17T+9 160+5 157+13 44+16 189+6 253+9 85+8
Table 5.2 Densitometric analysis o f  the effect o f  NT-3 and NT-3/LY294002 combined treatment on the 
phosphorylation status o f  Akt, MEK and ERK proteins. Data presented in the table are mean densitometric values 
gathered from three separate western blots.
Phosphorylation of MEK and ERK proteins in response to NT-3 stimulation shoAved a 
different pattern to that of Akt. At the point of NT-3 exposure, phosphorylated forms of MEK 
and ERKv^ere barely detectable. However, just 5 minutes after NT-3 stimulation 
phosphorylated forms of both proteins give a strong signal, which continued until the last time 
point examined, 35 minutes after addition of NT-3 to the cultures. Pretreatment with 
LY294002 had no effect on the maximal signal intensity observed for both MEK and ERK 
proteins (table 5.2, compare densitometric values of MEK and ERK signal at 35 minutes time 
point with 20 minutes time point for LY294002 treated cultures). However, their 
phosphorylation pattern was altered. In both cases phosphorylation levels increased until 20 
minutes after NT-3 exposure, with a subsequent decline of signal intensity, mimicking the 
pattern displayed by Akt. Also, a detectable levels of phosphorylated versions of both proteins 
were detected at the point of addition of NT-3, suggesting that it was independent of the 
actions of NT-3.
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Figure 5.10 Densitometric graphs o f western blots presented in figure 5.10. Densitometric peaks shown on the 
graphs correspond to the lanes on western blots for respective protein (Akt, MEK and ERK)
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5.4.3 Changes in the protein levels of bcl-2 and c-fos initiated by NT-3 or combined 
NT-3/LY294002 treatment.
After investigating the effect of NT-3 and combined NT-3/LY294002 treatments on upstream 
signalling molecules in the Pl-3K/Akt and MEK/MAPK pathways, the last set of experiments 
was performed to examine the changes in the status of downstream molecules of these 
pathways, bcl-2 and c-fos. Using the experimental design described previously (section 5.4.2), 
cell cultures treated with NT-3 with and without LY294002 were collected at 3 time points, 5, 
20 and 35 minutes after factor treatment. Western blots were performed in order to investigate 
the amount of total bcl-2 and c-fos present in the lysates. Due to the slower rate of changes of 
the total amount of these proteins (15 minutes average half-life of c-fos), cell lysates were not 
prepared from the cells directly after NT-3 treatment (0 minutes time point). Representative 
western blots immunolabelled against total bcl-2 and c-fos proteins are shown in Figure 5.11, 
with densitometric graphs corresponding to the western blots presented in Figure 5.12. The 
results of densitometric analysis are summarized in Table 5.3.
Both c-fos and bcl-2 show little variation in protein levels at all time points in the NT-3 treated 
cultures, although levels of c-fos are slightly elevated after NT-3 treatment compared to bcl-2. 
Pretreatment with the P1-3K inhibitor LY294002 affects c-fos as well as bcl-2, causing 
elevation in levels of both proteins at every time point examined compared to controls. 
Moreover, western blots and densitometric data suggest that changes in the protein levels 
observed for both c-fos and bcl-2 in the inhibited cultures might parallel the pattern of changes 
in phosphorylation levels showed by Akt, MEK and ERK. After an initial increase in the 
protein content of both c-fos and bcl-2 seen at 5 and 20 minutes after NT-3 treatment.
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compared to the respective times in control cultures, protein levels decreased between 20 and 
35 minutes after exposure to NT-3 (Fig 5.11 and 5.12, table 5.3).
control LY294002
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Figure 5.11 Western blotting against total bcl-2 and c-fos proteins. Cell cultures established as described in 
materials and methods were grown for 12 hours, and subsequently exposed to NT-3 at lOng/ml concentration. 
Cells were collected at 5, 20, and 35 minutes after NT-3 treatment and processed for western blotting. LY294002 
treatment was initiated 30 minutes before addition of NT-3 to allow inhibition o f PI-3K. 5pg o f  protein extracts 
was loaded on to each gel. To ensure equal protein content on each lane, membranes after electro blotting were 
incubated with ponceau red (top lane), and protein amounts were estimated using densitometry
control LY294002
5' 20' 35' 5' 20' 35'
c-fos 125±18 110+10 130+10 284+9 247+11 195+11
bcl-2 102+10 96+4 116+4 219+13 268+14 143+15
Table 5.3 Densitometric analysis o f  the effect o f NT-3 and NT-3/LY294002 combined treatment on the total 
amount o f bcl-2 and c-fos proteins. Data presented in the table are mean densitometric values gathered from three 
separate western blots.
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Figure 5.12 Densitometric graphs o f  western blots presented in figure 5.12. Densitometric peaks shown on the 
graphs correspond to the lanes on western blots for respective protein (c-fos and bcl-2)
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5.5 Discussion
There is good evidence supporting the roles of the PI-3K/Akt and MEK/MAPK pathways in 
signalling initiated by activation of Trk receptors [Kaplan et al. 2000]. Numerous neuronal 
populations, including sympathetic and cerebellar neurons [Dudek et al. 1997, Virdee et al.
1999] have been shown to employ these pathways in survival responses resulting from 
activation of Trk receptors.
PI-3K, an enzyme known to be involved in many survival responses in neuronal populations 
of both CNS and ENS was a target of preliminary experiments. To examine the role of PI-3K 
in the survival of enteric ganglion cells, cell cultures were grown for 12 or 36 hours (with 
either NT-3 or GDNF) with or without LY294002, a specific inhibitor of PI-3K. As expected, 
inhibition of PI-3K resulted in a marked decrease in the numbers of both glial and neuronal 
cells present in the cultures after 12 hours, which implies that PI-3K is required for survival of 
both cell types in vitro and perhaps in vivo.
Irrespective of factor treatment, glial cell numbers were comparable among uninhibited 
cultures. Similarly, cultures treated with LY294002 displayed comparable glial cell losses in 
all treatments which suggests that NT-3 and GDNF have only minor, if any, effect on glial cell 
numbers. This observation in turn suggests that enteric glia are less dependent on exogenous 
trophic factor support then enteric neurons. The diminished glial numbers in the cultures 
treated with LY294002 also show a crucial role of PI-3K in the survival of enteric glial cells in 
in vitro, and most likely in in vivo situation.
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LY294002 treatment caused a marked decrease in the numbers of neurons present in both 
cultures grown without factor support and grown with NT-3 and GDNF, compared to their 
respective, uninhibited controls. Cultures grown without factor support exhibited a 56% 
decrease in neuronal numbers compared to uninhibited control cultures. The neuronal loss was 
more extensive in the cultures grown with NT-3 or GDNF and LY294002, reaching an 
average of a 65% reduction.
The larger degree of neuronal loss in LY294002 treated cultures grown with NT-3 or GDNF 
compared to inhibited cultures grown without factors could be interpreted in two ways. The 
first possibility is that factor treatment increases neuronal death in cultures grown with 
LY294002. Alternatively, since the values of neuronal and glial cell loss were calculated as a 
ratio of the neuronal numbers in the respective controls to the neuronal numbers present in the 
inhibited cultures, higher death ratios could result from higher numbers of neurons present in 
the control cultures. This indeed seems to be the case, as at 12 hours time point cultures grown 
with either NT-3 or GDNF have higher numbers of neuronal cells compared to control 
(average 159 neurons per coverslip for controls, to 169 in NT-3 and 176 in GDNF treated 
cultures), which is also true at 36 hours.
Another important fact is the effect of PI-3K inhibition on the actions of NT-3 and GDNF on 
enteric ganglion cells. The average number of neurons per area counted in control cultures 
grown without inhibitor at 12 hours is 159, NT-3 increases that number to 189, while GDNF 
increases neuronal numbers to 176 (see Table 5.1). Addition of LY294002 to untreated, NT-3 
or GDNF treated cultures decreases these numbers to 69, 58 and 60, respectively. The effect of 
PI-3K inhibition is similar at 36 hours, where cultures grown without factor support have 
average 119 neurons per coverslip, NT-3 treated cultures 151 and GDNF treated cells 195
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neurons, which in case of GDNF exceeds the numbers of neurons at 12 hours. Inhibition of RI­
SK decreases these numbers to 30, 25 and 40, respectively. Both at 12 and 36 hours, inhibition 
of PI-3K blocks the effects of both factors bringing the number of neurons in each treatment to 
comparable level. This observation suggests that PI-3K is an important step in the signalling 
cascades initiated by both factors, since its inhibition nullifies the effects of both NT-3 and 
GDNF on enteric neurons, bringing cell numbers down to the levels observed in control.
The changes observed in LY294002 treated cultures were more pronounced after 36 hours. 
Both glial and neuronal populations displayed dramatic decreases in each treatment compared 
to controls. Interestingly, while initially (after 12 hours growth) inhibition of PI-3 K affected 
glia to lesser degree than neurons, at 36 hours glia and neurons were affected in similar way, 
displaying comparable degree of cell death. Glial cell numbers decreased by 50% in all 
treatments compared to uninhibited controls after 12 hours, after 36 hours glial cell numbers 
decreased by 83%, compared to 65% of neuronal loss at 12 hours and 84% at 36 hours in the 
LY294002 treated cells grown with factors.
Taken together, the data discussed above imply that (i) glial cells are relatively independent of 
neurotrophic factor support for survival, probably due to generation of other endogenous 
trophic factors, (ii) Survival of enteric glia is dependent on signalling pathways involving 
PI-3K, a hypothesis supported by greatly increased death rate of glia in cultures grown for 
both 12 and 36 hours with LY294002.
Based on the fact that even at 36 hours some cells are still present in the LY294002 treated 
cultures one more conclusion could be made. Enteric ganglion cells, or at least some 
populations of these cells, seem to be able to partially compensate for inhibition of PI-3K,
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perhaps by bypassing PI-3K and activating Akt by a different pathway or by ongoing 
activation of another pathway that is unaffected by PI-3K inhibition, which allows these cells 
to survive blockage of the primary, PI-3K/Akt survival pathway. Such a scenario is possible, 
considering that it has been proposed that Akt could be modulated by pathways other than the 
Ras/PI-3K pathway.
The next step was to investigate the molecules involved in signalling cascades initiated by NT- 
3/Trk receptor, as well as changes in signalling events caused by inhibition of PI-3K. Data 
obtained in previous chapters indicated that while NT-3 has the ability to promote survival 
responses in cultured enteric ganglion cells, the effect of GDNF is mainly to increase cell 
numbers in the cultures, possibly by inducing proliferation of precursor cells. Considering 
these observations, NT-3 seemed to have more potential as a possible factor in therapies 
designed to prevent or reduce neuronal losses associated with oxidative stress in adults than 
GDNF, since it is unlikely that adult gut might contain sufficient cells able to respond to 
proliferative signals. For that reason, only NT-3/Trk initiated signalling cascades were 
examined in this series of experiments.
Due to rapid changes in the phosphorylation status of signalling molecules after signal 
initiation, a different experimental design was used than previously. Cell lysates were prepared 
from cell cultures in short intervals after exposure to NT-3 with and without LY294002, up to 
maximum of 35 minutes after the beginning of the experiment. The results of these 
experiments show constant levels of Akt phosphorylation across every time point examined, 
including the time of NT-3 addition, independent of NT-3 treatment. These results suggest that 
the PI-3K/Akt pathway is crucial for survival of enteric ganglion cells, and as such is likely to
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be constitutively active especially in in vitro conditions, a conclusion supported by the results 
of the previous experiments.
Not surprisingly, LY294002 pretreatment reduced the amount of phosphorylated Akt present 
in the cells, as well as the time frame of Akt phosphorylation. Levels of phosphorylated Akt 
remained lower in inhibited cultures compared to controls, however, a slight increase in the 
strength of western blot signal occurred between 0 and 20 minutes after NT-3 treatment, 
confirmed by densitometric analysis of western blots. Levels of phosphorylated Akt seemed to 
decline after 20 minutes, which continued until the last time point examined. This observation 
suggests that NT-3 signalling is able to affect phosphorylation of Akt, an effect that could be 
masked by constitutively high levels of phosphorylated Akt present in uninhibited cultures.
The increase of phosphorylated Akt in the inhibited cultures most likely is not linked with PI- 
3K which could imply that that Akt phosphorylation might be regulated not only by PI-3K, but 
also by another pathway, independent of PI-3 K.
Investigation of MEK and ERK proteins, participating in the second major signalling pathway 
present in the neurons, revealed a different behaviour than that observed for Akt. 
Phosphorylated forms of both proteins are undetectable at the moment of NT-3 treatment, 
however they undergo rapid phosphorylation as a result of activation of the Trk receptor, and 
give a strong signal beginning from 5 minutes after NT-3 treatment, continuing until the last 
time point examined. A double band was observed in case of ERK corresponds to two 
isoforms of ERK protein. A lack of clear differences in the intensity between these bands 
suggests that NT-3 stimulation affects phosphorylation of both isoforms to the same degree.
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The rise in the amount of phosphorylated forms of MEK and ERK proteins following NT-3 
stimulation suggests that the MEK/MAPK pathway, in contrast to the PI-3K/Akt pathway, is 
not constitutively active in the enteric ganglion cells, and instead is activated in response to 
exogenous trophic factor stimulation. Although not performed in this study, use of specific 
inhibitors of MEK kinase should confirm this hypothesis.
One explanation of this result could be that while the PI-3K pathway is mainly involved in cell 
survival (as discussed in section 5.1.2), primary actions of the MEK/MAPK pathway are 
induction of differentiation or cell proliferation [Grewal et al. 1999]. In the light of these facts 
it is feasible to assume that the effects of both NT-3 treatment, such as neurite outgrowth 
observed in the cultures of enteric ganglion cells, as well as increases in neuronal numbers 
observed in cultures grown with GDNF are at least partially dependent on MEK/MAPK 
signalling. These actions of the MEK/MAPK pathway can also explain induction of signalling 
along this pathway upon NT-3 stimulation, and lack of MEK/MAPK phosphorylation in the 
absence of trophic factor, since the activation of this pathway seems to depend on extracellular 
stimuli inducing differentiation responses, which are not required for neuronal survival.
Inhibition of PI-3K changed the time course of phosphorylation of both MEK and ERK. In 
contrast to controls, LY294002 treated cells show small, but detectable levels of 
phosphorylated forms of these proteins at the point of NT-3 addition with subsequent raise of 
signal strength which peaks 20 minutes after NT-3 treatment and declines afterwards. Since 
the maximum intensity of the bands for both MEK and ERK obtained in western blots 
performed on lysates from LY294002 treated cultures is comparable to uninhibited controls, it 
stands to reason that phosphorylation of MEK and ERK is not dependent on PI-3K, which 
remains in accordance with generally accepted view.
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The small increase in the amount of phosphorylated MEK and ERK seen at the point of NT-3 
stimulation in the inhibited cultures might indicate that cells devoid of PI-3K activity initiate 
other pathways promoting cell survival, for example MEK/MAPK and perhaps some others. If 
true, it might explain small levels of phosphorylated MEK and ERK observed at the point of 
NT-3 exposure, considering that inhibitor of PI-3K was added 30 minutes before addition of 
NT-3, which allows the cells to initiate alternative survival signalling before addition of NT-3 
to the cultures. The initial increase of phosphorylation levels of MEK and ERK seen in the 
cultures treated with LY294002 and the subsequent decrease beginning 20 minutes after NT-3 
exposure could be explained in several ways. Perhaps the most likely explanation is that NT-3 
initiated signalling requires interplay between PI-3K/Akt and MEK/MAPK pathways for 
continuous activity of both pathways. In the situation where PI-3K signalling is removed, the 
MEK/MAPK pathway does not receive feedback and its activity decreases, which could 
explain drop in the phosphorylation levels of both MEK and ERK after 20 minutes after NT-3 
treatment.
Interestingly, the time course of changes in the levels of phosphorylated MEK and ERK in the 
inhibited cultures are similar to these observed in case of Akt. This suggests interaction 
between PI-3K/Akt and MEK/MAPK pathways, perhaps even existence of a feedback 
between Akt and MEK/MAPK. However, more data are required to validate this hypothesis.
The last set of experiment was focused on the downstream effectors of both PI-3 K/Akt and 
MEK/MAPK pathways, namely bcl-2 and c-fos proteins. Using western blots, the levels of 
total bcl-2 and c-fos were examined in uninhibited, as well as LY294002 treated cultures. Both 
proteins are detectable at every time point examined, and their levels remain constant.
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Addition of LY294002 results in marked increase of both bcl-2 and c-fos protein content in 
the cell lysates, compared to uninhibited controls. Similarly to Akt, MEK and ERK, levels of 
bcl-2 and c-fos in the inhibited cultures decrease after 20 minutes, which parallels the decrease 
in the phosphorylation levels observed for Akt, MEK and ERK. Since both bcl-2 and c-fos are 
downstream effectors of many pathways, including both the PI-3 K/Akt and MEK/MAPK 
pathways, it stands to reason that changes in the activity of these pathways might be 
accompanied by similar changes of effector molecules, such as bcl-2 and c-fos.
Taken together the results obtained in this study confirm the role of PI-3K/Akt as an important 
survival pathway in both enteric neurons and glial cells. Inhibition of PI-3K caused dramatic 
decrease in the numbers of cells present in the cultures. Such an effect is most likely 
associated with decrease in the phosphorylation of Akt. Since Akt is known to repress several 
pro-apoptotic proteins, decrease of Akt activity is likely to cause an activation of these 
proteins, resulting in the initiation of the cell death program, which is the most likely the 
reason for the observed decrease in the numbers of neurons and glial cells. The data 
confirming this assumption come from western blots, which showed constant, high levels of 
Akt phosphorylation in the uninhibited cultures, supporting the role of PI-3K/Akt pathway in 
the survival of enteric ganglion cells. Although the data gathered in this study describe an in 
vitro situation, it is feasible to assume that PI-3K signalling plays equally important role in 
vivo.
To summarize, the experiments described in this chapter provide data confirming the role of 
PI-3K/Akt signalling pathway in survival of enteric ganglion cells in vitro. Furthermore, a role 
of MEK/MAPK pathway was established as one of the signalling pathways underlying the 
effects of NT-3, and possibly GDNF on enteric ganglion cells in culture.
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Chapter 6
General discussion
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There is considerable evidence documenting changes occurring in the gut of aged animals.
One of the hallmark features of aging in the gut is the loss of enteric neurons [Gabella et al. 
1989, Santer et al. 1988], which is likely to contribute to the numerous disorders of 
gastrointestinal tract observed in elderly. Although there are no practical means of reversing 
the effects of aging in humans available to date, caloric restriction has been consistently 
shown to prevent at least some age-associated changes in every animal model examined, from 
the nematode C. elegans to rats.
A considerable amount of research has been focused on finding methods to counteract 
age-related changes in humans. Due to its beneficial effects in animal models, caloric 
restriction has drawn some attention as a promising avenue of research. The results of several 
studies demonstrate that caloric restriction alters the expression of a broad spectrum of 
proteins, ranging from metabolic enzymes to free radical scavenging enzymes, as well as 
reducing generation of free radicals due to the more efficient usage of available energy sources 
[Hagopian et al. 2002]. It has been demonstrated that in calorically restricted animals 
neurotrophic factor treatment can further reduce free radical production in the gut in vitro 
[Kim et al. 1997, T. Cowen, personal communication]. Based on those observations, current 
study has been undertaken in order to find out the possible protective role played by NT-3 and 
GDNF in the survival of enteric ganglion cells, especially enteric neurons, in vitro.
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The protective effects o f neurotrophic factors against H2O2 induced death.
The first set of experiments, described in chapter 3, investigated the effects of NT-3 and 
GDNF on the cultures of enteric ganglion cells exposed to oxidative stress induced by H2O2 . 
Not surprisingly, H2O2 treatment reduced cell numbers in the cultures. Simultaneous addition 
of NT-3 had a slight protective effect on cell viability, measured using MTS assay, Avhile no 
such effect was detected for GDNF. In a separate series of experiments counts of 
Hoechst/propidium iodide stained cultures exposed to H2O2 in conjunction with the factor 
treatment showed a significant reduction in the number of dead cells present in the H2O2 
treated cultures that received NT-3 compared to controls, which reinforced the data obtained 
in MTS assays. These data remain in agreement with the results of other studies showing 
beneficial effects of neurotrophins on neuronal cells exposed to oxidative stress [Heaton et al. 
2000, Miyazaki et al. 1999].
The difference in the protective effect of NT-3 observed using MTS assay and 
Hoechst/Propidium iodide staining could stem from different sensitivity of the two methods. 
While MTS offers a fast way of examining the changes of cell viability, it is able to detect 
only gross changes occurring in the cultures, while counting cells labelled with 
Hoechst/Propidium iodide is a much slower, but also more accurate method. On the other 
hand, GDNF was not able to counteract cell death in H2O2 treated cultures, instead increasing 
both neuronal and glial cell numbers in the control cultures. Interestingly, H2O2 treatment 
abrogated this effect. The explanation of this phenomenon could be that cell death resulting 
from H2O2 exposure, or perhaps signalling pathways in the cells activated by exposure to H2O2 
[Kim et al. 1997, Cabalerro et al. 1997] interfered with signalling required for GDNF to exert 
its effects on the cells.
142
Similarly, cultures exposed to combined NT-3 and GDNF treatment without H2O2 behaved in 
a manner comparable to control cultures, implying that NT-3 and GDNF, when applied 
simultaneously, can nullify each other's effects. Since in the experimental model used in this 
study NT-3 treatment induced a differentiation response in the cultures, such as neurite 
outgrowth, while GDNF induced proliferation it is possible that activation of these conflicting 
pathways, that is differentiation and proliferation at the same time was the cause of a reduction 
of the effect of both NT-3 or GDNF in the combined treatment. The intracellular mechanism 
responsible for this effect might include competition for signalling molecules between 
pathways conveying signals initiated by NT-3 and GDNF, since both factors employ similar 
signalling events to convey their effects [Kaplan et al. 1997]. Another possibility could be that 
end effects of pathways induced by GDNF and NT-3 are mutually exclusive, in which case 
responses initiated by both factors would nullify each other.
The effects o f  neurotrophic factors on the expression o f  catalase and SOD Cu/Zn.
The results discussed in chapter 3 raised another question, that is of the mechanism 
responsible for the protective effect of NT-3. One possible explanation, supported by the 
results obtained by other groups, is that NT-3 treatment might increase the expression or 
activity of antioxidant enzymes present in the cultures, as has been documented for other 
neurotrophic factors [Chao et al. 1999], thereby reducing the amount of oxidative damage to 
the cells and decreasing the amount of cell death. To test this hypothesis, protein levels of two 
of the antioxidant enzymes present in enteric ganglion cells, catalase and SOD Cu/Zn, were 
examined using western blotting as described in the results of chapter 4. The results indicated 
no significant changes in the levels of these enzymes after 12 hours incubation with either
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NT-3 or GDNF. 36 hours treatment with NT-3 resulted in a small decrease in the levels of 
SOD Cu/Zn. Similar treatment with GDNF caused significant increase in the levels of both 
catalase and SOD Cu/Zn, compared to controls.
At first sight this result seems somewhat contradictory to the protective effects of NT-3 
observed earlier. However, one has to bear in mind the difference in the experimental design 
used in the two sets of experiments. While preliminary experiments focused on the short term 
protective effects of NT-3 and GDNF subsequent experiments concentrated on the longer-term 
effect of factor treatment on the expression of antioxidant enzymes. This difference might 
explain the discrepancy between the results of the two sets of experiments. However, since 
NT-3 treatment does not have significant effects on the levels of the two antioxidant enzymes 
tested, that is catalase and SOD Cu/Zn, it seems more feasible to assume that the protective 
effects of NT-3 are associated either with increased protein levels of other antioxidant 
enzymes, for example SOD Mn, or increased activity of antioxidant enzymes present in the 
cells. Other possible mechanisms by which NT-3 might convey its protective effects are 
discussed later.
Since prolonged GDNF treatment increased protein levels of both the antioxidant enzymes 
tested, a possibility arises that GDNF treatment might offer protection against oxidative insults 
upon prolonged exposure. If true, such an effect could make GDNF an attractive target of 
therapies focused on preventing neuronal losses resulting from oxidative stress. However, 
more data are required to validate this hypothesis.
To address the question of possible differential expression of the two enzymes by neurons and 
glial cells as well as the contribution of both cell types to the total cell numbers present in the
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cultures, cells grown for 12 and 36 hours were fixed and immunolabelled using the antisera 
raised against catalase and SOD Cu/Zn or PGP 9.5, respectively. Catalase and SOD Cu/Zn 
immunostaining shows strong, clear staining of neurons and weaker staining of glial cells, 
with staining intensity of both cell types comparable between cultures stained at 12 and 36 
hours. This observation suggests that neurons might contain higher levels of both enzymes 
than glial cells, which stands to reason if one considers higher metabolic rate of neuronal cells 
compared to glia, and resulting requirement for more robust defence systems.
Cell counts of PGP 9.5 stained cultures revealed that while the neuron to glial cell ratio 
decreased in both control and NT-3 treated cultures at the 36 hours time point, it remained 
almost constant in the GDNF treated cultures. This fact, together with the increase in both 
neuronal and glial cell numbers that seems to take place between 12 and 36 hours suggests that 
GDNF is able to induce proliferation in the cultures of enteric ganglion cells used in this 
study, which confirms the results of cell counts performed on Hoechst/propidium iodide 
stained cultures. Taken together, those results suggest that both neurons and glial cells 
contribute to the increase in the levels of SOD Cu/Zn and catalase observed in the cultures 
grown with GDNF for 36 hours. The fact that increases in the levels of catalase and SOD 
Cu/Zn were only seen after prolonged incubation with GDNF might explain the lack of 
protective effect of GDNF observed previously in the cultures exposed to H2O2 after 12 hours.
Taken together, the results from investigation of the effects of NT-3 and GDNF treatment on 
the levels of catalase and SOD Cu/Zn argues against the hypothesis that the protective effect 
of NT-3 on H2O2 treated cultures observed earlier is due to NT-3 dependent increase of the 
levels of these enzymes, although it cannot be ruled out that NT-3 is able to affect other 
antioxidant enzymes, such as SOD Mn or GPx, which might at least partially contribute to the
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protective effect of NT-3. Alternatively, NT-3 treatment could affect the activity of 
antioxidant enzymes instead of increasing their protein levels. Such an effect might explain the 
protective effects of NT-3 and the lack of its effect on the levels of anti oxidant enzymes 
present in the cultures.
The effects o f  neurotrophic factors on signalling pathways in enteric ganglion cells.
Another possible explanation of the protective effect of NT-3 is that the intracellular signalling 
events initiated by NT-3 treatment are able to override the death program initiated by H2O2 .
To address the question of a possible molecular mechanisms employed by NT-3 to convey its 
protective effects, intracellular signalling cascades initiated by NT-3 have been examined, as 
described in chapter 5. The first step was to assess the role of PI-3K, an enzyme involved in 
survival responses in numerous neuronal populations [Virdee et al. 1999, Kaplan et al. 2000] 
in the NT-3 induced signalling in enteric ganglion cells in vitro. A specific inhibitor of PI-3K, 
LY294002, was used on cultures grown with NT-3 or GDNF for 12 or 36 hours, and the 
effects of PI-3K inhibition were assessed by cell counts of PGP 9.5 stained cultures.
The results clearly indicated the importance of PI-3 K signalling to the survival of enteric 
ganglion cells in vitro. Inhibited cultures, regardless of factor treatment, showed extensive cell 
loss after 12 hours, which increased at 36 hours. Both neuronal and glial cell populations were 
affected by LY294002 treatment. At the 12 hour time point, glial cells exhibited smaller losses 
compared to neurons, however between 12 and 36 hours the death rate of glial cells increased, 
resulting in similar loss of glial and neuronal cells at 36 hours.
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Although neither NT-3 nor GDNF treatment were able to rescue the cells from the effects of 
PI-3K inhibition, neuronal death rate was slightly different between NT-3 and GDNF treated 
cultures while glial cells were affected in the same manner in each condition. This observation 
suggests that glial cells might be less dependent on neurotrophic factor signalling than 
neurons. This effect could be caused by the production of endogenous trophic factor support 
by glial cells. However, it seems that PI-3K signalling is required for survival of glial cells as 
well as neurons, as shown by similar degree of cell death in both populations after 36 hours 
exposure to PI-3K inhibitor.
Having established that PI-3K is necessary for the survival of enteric ganglion cells, the 
signalling events occurring in the enteric ganglion cells after NT-3 stimulation were 
investigated. It is believed that in neurons signalling initiated by binding of neurotrophins to 
their cognate receptors follows two major pathways, that of Ras/PI-3K/Akt and MEK/MAPK 
pathway [see Kaplan et al. 2000]. Based on this fact three proteins participating in propagation 
of the signal along these pathways were chosen, that is Akt, MEK and ERK, and their 
phosphorylation status corresponding with activation of these proteins was examined using 
western blotting.
Steady, easily detectable levels of phosphorylated Akt were detected at every time point in the 
cultures not treated with LY294002, beginning from the point of NT-3 stimulation to 35 
minutes after the beginning of the experiment. Considering the fact that Akt is a main 
downstream target of PI-3K signalling, responsible for inhibition of several pro-apoptotic 
proteins [Dudek et al. 1997], such constant activation of Akt is not surprising, especially taken 
together with the detrimental effects of PI-3K inhibition on the survival of enteric ganglion 
cells. This result implies that ongoing activity of Akt is necessary for survival of enteric
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ganglion cells in vitro, and quite likely also in vivo and that at least in the in vitro situation, 
activation of Akt is independent of signalling initiated by exogenous trophic factors.
The results obtained for MEK and ERK proteins were different to those of Akt. At the time of 
NT-3 stimulation the levels of phosphorylated forms of both proteins were not detectable in 
the cultures untreated with PI-3K inhibitor, however they rose just 5 minutes after NT-3 
treatment and remained consistently high until the last time point examined. Considering that 
there are data suggesting that the MEK/MAPK pathway is involved in differentiation 
responses initiated by neurotrophin signalling in neuronal cells [Traverse et al. 1992], one 
might expect that NT-3 treatment would induce signalling along the MEK/MAPK pathway 
because morphological changes were induced by NT-3 stimulation in the cultures of enteric 
ganglia observed in this study.
Two downstream effector proteins activated by both the PI-3K7Akt and MEK/MAPK 
pathways were also studied. However, neither total protein levels of bcl-2 nor c-fos protein 
changed in the uninhibited cultures in the course of experiment, although they were readily 
detectable at every time point examined. In case of c-fos, this result most likely reflects the 
ongoing signalling events taking place in the cells, and remains in accordance with well- 
documented role of c-fos as a transcription factor activated in response to a range of stimuli 
both in vivo and in vitro [Sainz et al. 1998, Setemes et al. 1998]. The presence of bcl-2 protein 
might be related to its function as an anti-apoptotic protein [Seyfi’ied et al. 2003], since it is 
likely that in the in vitro cultures where conditions are different from in vivo situation 
increased levels of bcl-2 might protect the cells from apoptosis.
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The levels of Akt, MEK, ERK, bcl-2 and c-fos differed significantly in the NT-3 treated 
cultures pretreated with LY294002 inhibitor. Levels of phosphorylated Akt were markedly 
reduced compared to uninhibited controls. Nevertheless, densitometric analysis of western blot 
membranes showed a small increase in the amount of phosphorylated Akt 20 minutes after 
NT-3 addition, after which a decrease of signal occurred.
Although inhibition of PI-3K did not affect the maximum degree of phosphorylation of MEK 
and ERK, the time course of phosphorylation of both proteins was similar to that of Akt. 
Phosphorylated forms of both proteins were detected at the point of NT-3 treatment, indicating 
that some signalling events took place before NT-3 stimulation. It could be hypothesized that, 
since the primary survival pathway has been inactivated by PI-3K inhibition, the MEK/MAPK 
pathway might have been activated in order to compensate for the absence of PI-3K survival 
signalling. On the other hand, changes in the phosphorylation levels of MEK and ERK could 
also be related to the possible interplay between PI-3K/Akt and MEK/MAPK pathways.
Analysis of western blots indicated that after addition of NT-3, the levels of phosphorylated 
MEK and ERK increased in a manner similar to that observed for Akt, with a subsequent 
decrease in the amount of phosphorylated forms of both MEK and ERK beginning 20 minutes 
after NT-3 treatment. This similar time course of phosphorylation of Akt, MEK and ERK after 
NT-3 stimulation suggests existence of interplay between PI-3K/Akt and MEK/MAPK 
pathways. Interestingly, changes in bcl-2 and c-fos levels followed the same pattern. In the 
inhibited cultures levels of both proteins are increased compared to controls, and both bcl-2 
and c-fos levels showed a decrease 20 minutes after NT-3 stimulation. One possible 
explanation of this behaviour could be that since the signalling along the PI-3K/Akt and 
MEK/MAPK pathways seemed to decrease in the inhibited cultures at the same time, that is
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20 minutes after NT-3 application, which might be closely followed by their downstream 
effectors such as c-fos and bcl-2.
Taken together, these results indicate that both the PI-3K/Akt and MEK/MAPK pathways are 
activated by NT-3 binding to its receptor, even though such activation is masked in the case of 
the PI-3 K/Akt pathway due to intrinsic high levels of phosphorylation of Akt which are 
independent of exogenous NT-3 signalling.
Inhibition of PI-3K provides an interesting insight into the actions of both pathways.
Akt is directly affected by PI-3K inhibition, as a downstream target of PI-3K Surprisingly, 
inhibition of PI-3K also affects the MEK/MAPK pathway, as shown by the change of time 
course of phosphorylation of both MEK and ERK upon PI-3K inhibition. Considering the 
decrease of signal strength from phosphorylated forms of MEK and ERK observed in the 
cultures pretreated with LY294002, mimicking the pattern displayed by Akt, it seems possible 
that there is some degree of interaction between the PI-3K/Akt and MEK/MAPK pathways. 
Another fact supports this theory. PI-3K signalling has been blocked in LY294002 treated 
cultures, yet Akt showed an increase of phosphorylation in response to NT-3 treatment. It 
could be argued that PI-3K has not been completely blocked by LY294002, and that Akt has 
been phosphorylated by residual activity of PI-3K. However, this does not seem likely, as 
high concentration of LY294002 used in the experiments, as well as the time between addition 
of an inhibitor and factor treatment should be able to block all residual PI-3K activity 
irreversibly. Another possible explanation is that a rise in Akt phosphorylation might have 
been caused by interaction with components of MEK/MAPK pathway [Zimmermann et al. 
1999].
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Based on these results, a possible model of NT-3 initiated signalling and its effects on the 
cultures of enteric ganglion cells is shown in Figure 6.1.
NT-3NT-3
RasRas
MEKPI-3KMEKP1-3K
AktAkt
► c ERK ERK
ForkheadForkhead Bcl-2
Survival Apoptosis
Fig. 6.1 Putative model o f NT-3 induced signalling pathways (A) and the effects o f  PI-3K inhibition (B) in the 
entenc ganglion cells. Dashed line between Akt and ERK marks possible interaction between these proteins, 
suggesting the existence o f a regulatory feedback between PI-3K/Akt and MEK/MAPK pathways. For more 
details see text.
NT-3, upon binding to its receptor initiates its phosphorylation. Subsequently, signal is 
transduced along the Pl-3K/Akt and MEK/MAPK pathways, resulting in promotion of cell 
survival by reinforcing Akt stimulation and promoting differentiation responses as a result of 
MEK/MAPK signalling. LY294002 inhibition abrogates PI-3K signalling, resulting in 
deactivation of Akt, which in turn leads to derepression of pro-apoptotic molecules resulting in 
cell death. The putative interaction between Akt and MEK/MAPK pathway has also been
151
Although signalling cascades initiated by GDNF were not examined, it seems likely that 
GDNF signalling is not able to counteract the inhibition of PI-3K. This hypothesis is 
supported by the cell counts of cultures grown with combined GDNF and LY294002 
treatment, where GDNF was not able to rescue either glia or neurons from cell death resulting 
from PI-3K inhibition.
Conclusions
The research undertaken in this study was based on the observation that caloric restriction 
increases neuronal survival, and also on the results obtained by Thrasivolou et. al. showing 
decreased amount of free radicals detected in the gut of calorically restricted animals, resulting 
from NT-3 treatment in vitro [Thrasivolou et al. 2000]. The goal of work described in previous 
chapters was to answer the question whether NT-3 and GDNF can protect enteric ganglion 
cells in vitro from oxidative stress, and also what mechanisms are responsible for the gross 
effects of these factors. Due to the high complexity of these processes, many interesting issues 
have not been addressed; some of them are discussed below.
The protective effects of NT-3 on enteric ganglion cells described above may well be due to 
the an end effect of several intracellular processes not examined here. Although decreased 
generation of free radicals does not seem likely due to short time frame of these experiments, 
which precludes synthesis of new proteins required for increased efficiency of the 
mitochondrial electron transport chain, other mechanisms can contribute to the observed 
protective effects of NT-3 and decreased amount of free radicals detected after NT-3 treatment 
by Thrasivolou et. al.
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Several groups have reported increase in the activity of antioxidant enzymes after trophic 
factor treatment [Chao et al. 1999, Spina et al. 1992]. Such an effect might not be dependent 
on de novo synthesis of these enzymes, but instead on altering efficiency of existing 
antioxidant enzymes present in the cells. If true, such action of neurotrophic factors would not 
require long periods of time to take effect, which fits in with the results of this study.
Another possibility is that NT-3 treatment might affect expression of antioxidant enzymes 
other than the ones tested in this study. Mitochondrial SOD or GPx are likely candidates.
A novel observation of this study is the ability of GDNF to increase levels of catalase and 
superoxide dismutase in enteric ganglion cells after prolonged incubation. Such an effect 
remains in agreement with results of other groups, showing comparable increases not only in 
catalase and SOD Cu/Zn, but also GPx levels in vivo [Chao et al. 1999]. Simultaneous 
increase in the levels of all these proteins is an important fact, since increase in the levels of 
SOD Cu/Zn without parallel increase in catalase/GPx levels is thought to promote oxidative 
stress [Huang et al. 1992].
The impact of NT-3 on intracellular signalling cascades promoting cell survival rather than 
cell death could also contribute to the protective effect of NT-3. It is known that in case of 
some cell types increased expression of transcription factor CREB (cAMP response element 
binding protein) is sufficient to promote cell survival [Riccio et al. 1999]. This protein is a 
likely target of neurotrophic factor induced survival responses, as both the PI-3K/Akt and 
MEK/MAPK pathways are able to activate this protein [Bonni et al. 1999, Du et al. 1998]. In 
case of MEK/MAPK pathway activation of CREB is somewhat indirect, as it requires 
activation of Rsk proteins, a downstream effectors of ERK that in turn activate CREB [Bonni
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et al. 1999]. Rsk proteins are able to promote survival in yet another way, by inhibition of 
Bad.
All these proteins offer attractive targets of therapies designed to prevent neuronal losses due 
to oxidative stress. The question of practical application of these data remains, however. To 
date, gene therapies or grafting modified cells are a popular approach to counteract adverse 
effects of oxidative stress and other conditions resulting in neuronal loss [Dumas et al. 2001, 
Naoi et al. 2001]. Both these methods use neurotrophic factors as means of protecting the 
cells. Although not yet feasible for practical trials, it is possible that therapies targeting 
particular genes, for example those of antioxidant enzymes or survival promoting proteins, 
like CREB or bcl-2 family will become available in close future.
Another approach to counteracting deleterious effects of oxidative stress are chemical 
compounds with free radical scavenging properties, or alternatively chemicals that mimic 
actions of certain antioxidant enzymes removing free radical species from the cells.
In both gene manipulation techniques and the more direct approach of chemical compounds 
with antioxidant properties, delivery to specific cell types is likely to pose a major obstacle. 
However, viral vectors and targeted liposomes are promising tools, able to deliver DNA/RNA 
or proteins and chemicals to specific cell types. Although in the stage of tests, these delivery 
systems show great promise as useful tools in therapies preventing neuronal loss.
In conclusion, the data gathered in this study supports the role of NT-3 as a survival factor for 
enteric neurons and glial cells, as shown by increased cell numbers in the cultures exposed to 
H2O2 with NT-3 treatment. The protective effect of NT-3 does not depend on increased levels
154
of catalase or SOD Cu/Zn and is detectable within 6 hours after NT-3 stimulation, which 
suggests that NT-3 treatment might offer an effective short term means of counteracting 
neuronal cell death caused by oxidative stress in vitro.
GDNF has not been able to rescue enteric ganglion cells from death induced oxidative damage 
after 6 hours exposure, instead inducing cell proliferation. However, GDNF dependent 
increases in the levels of catalase and SOD Cu/Zn after 36 hour exposure suggest that 
prolonged GDNF treatment might offer an effective protection against free radical damage. 
Such an effect makes GDNF a promising target of a long-term therapies aimed at preventing 
oxidative damage, and associated with it neuronal loss.
Future directions
The results of the experiments conducted in this study revealed several interesting facts 
concerning both the effects of neurotrophic factors on cellular antioxidant defences as well as 
signalling pathways responsible for protective actions of NT-3 and GDNF.
Nevertheless, many interesting issues remain to be addressed.
For example, in the culture model employed in this study both glial and neuronal cells are 
present. This fact could influence the behaviour of the two types of cells in response to 
exogenous factor stimulation or stress conditions, due to the endogenous trophic factor 
production and secretion by glial cells. Although separation techniques, for example gradient 
centriftigation would be hard to employ here due to small amount of cells obtained in 
preparations, seeding cells at lower density than used in this work might partially solve the 
problem of the interaction between glia and neurons, perhaps offering more accurate data.
155
Another issue is the way of inducing oxidative stress used in the experiments. Although H2O2 
is a popular means of inducing oxidative stress, adding it to culture medium allows it to react 
with cellular components present on the cell surface before H2O2 penetrates into the cell. This 
might disturb the picture obtained from the experiments for two reasons. First, the oxidative 
stress will be more severe close to the point where H2O2 was added to the culture, and second, 
since H2O2 reacts with all cellular components as it penetrates the cell, it does not resemble the 
in vivo situation where H2O2 dissociates from mitochondria and reacts with surrounding cell 
components. Due to these facts, reaction of the cells to oxidative stress induced in this way 
might not reflect in vivo situation.
A way to circumvent these difficulties would be to use chemical compounds increasing free 
radical production in the mitochondria, for example menadione.
The experiments performed in this study concentrated on the effects of NT-3 and GDNF on 
only two antioxidant enzymes, catalase and SOD Cu/Zn. Both are important steps in the 
process of removal of free radicals. However, neither mitochondrial SOD Mn, nor glutathione 
enzymes were examined. It is possible that although NT-3 does not affect protein levels of 
catalase and SOD Cu/Zn, it might affect levels of SOD Mn, GPx or GR, at least upon 
prolonged incubation with NT-3. Since the protective effects of NT-3 were rapid, a likely 
explanation would be the effect of NT-3 on the activity of antioxidant enzymes present in the 
enteric ganglion cells since it might require less time than affecting de novo expression of 
enzyme molecules. Similar questions are also relevant in case of GDNF.
Due to the difficulty in obtaining sufficient amount of proteins for western blotting, cultures 
designed for protein extracts were not subjected to H2O2 . One has to bear in mind, however,
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that H2O2 exposure in itself is likely to initiate signalling events [Lai et al. 1996]. Considering 
this fact, the results gathered in this study, based on the changes of signalling pathways upon 
trophic factor stimulation might not reflect all signalling events that take place in the cells 
subjected to both NT-3 and H2O2 . Addressing this issue would be a valuable addition to the 
experiments described in this work.
There are also quite interesting issues remaining to be answered, concerning the NT-3 initiated 
signalling events and resulting cellular responses. It is known that the duration of the trophic 
factor stimulus can result in different cellular responses, which might range from increasing of 
cell survival to initiation of cell death. In this study, only short term effects of NT-3 
stimulation on signalling pathways were examined. It might be interesting to investigate 
whether prolonged NT-3 exposure would have different effects, especially in conjunction with 
H202 induced oxidative stress. Also, only few selected signalling molecules were examined. 
Investigating the effect of NT-3 stimulation on molecules directly involved in initiating cell 
survival, such as CREB, or cell death such as p53 or JNK might be a valuable 
complementation of the results of this study.
The result of this work, as well as result obtained by other groups suggest existence of 
functional interplay between PI-3K/Akt and MEK/MAPK pathways. Although not 
investigated in this study, such interplay might be crucial for determining final outcome of 
specific trophic factor stimulation, and as such might be important for devising strategies of 
preventing neuronal death occurring as effect of oxidative stress in vivo.
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